www.europeanpharmaceuticalreview.com Open in urlscan Pro
2606:4700:3108::ac42:2bbe Public Scan

Go To Rescan
Add Verdict Report

URL:
https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-com...
Submission: On September 06 via api (September 6th 2023, 6:31:47 pm UTC) from US — Scanned from DE

Summary HTTP 207 Redirects Links 28 Behaviour Indicators

Summary

This website contacted 27 IPs in 4 countries across 23 domains to perform 207 HTTP transactions. The main IP is 2606:4700:3108::ac42:2bbe, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.europeanpharmaceuticalreview.com. The Cisco Umbrella rank of the primary domain is 648296.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on April 18th 2023. Valid for: a year.

This is the only time www.europeanpharmaceuticalreview.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
2 115	2606:4700:310... 2606:4700:3108::ac42:2bbe	13335 (CLOUDFLAR...) (CLOUDFLARENET)
3	2a00:1450:400... 2a00:1450:4001:808::200a	15169 (GOOGLE) (GOOGLE)
1	2606:4700::68... 2606:4700::6812:acf	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700:e0:... 2606:4700:e0::ac40:660b	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6810:3965	13335 (CLOUDFLAR...) (CLOUDFLARENET)
4	2a00:1450:400... 2a00:1450:4001:831::200e	15169 (GOOGLE) (GOOGLE)
6	2606:4700::68... 2606:4700::6812:d73b	13335 (CLOUDFLAR...) (CLOUDFLARENET)
7	2a00:1450:400... 2a00:1450:4001:803::2004	15169 (GOOGLE) (GOOGLE)
2	51.140.49.131 51.140.49.131	8075 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
4	2606:4700::68... 2606:4700::6811:180e	13335 (CLOUDFLAR...) (CLOUDFLARENET)
6	2a00:1450:400... 2a00:1450:4001:80e::2008	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:82b::200e	15169 (GOOGLE) (GOOGLE)
3	2a00:1450:400... 2a00:1450:400c:c0c::9a	15169 (GOOGLE) (GOOGLE)
5	2a00:1450:400... 2a00:1450:4001:831::2003	15169 (GOOGLE) (GOOGLE)
10	2a00:1450:400... 2a00:1450:4001:801::2003	15169 (GOOGLE) (GOOGLE)
2	2001:4860:480... 2001:4860:4802:32::36	15169 (GOOGLE) (GOOGLE)
1	37.221.223.17 37.221.223.17	51514 (SPOTLER S...) (SPOTLER Spotler Network)
2	2a02:26f0:480... 2a02:26f0:480:f::213:7ec6	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
2	2a00:1450:400... 2a00:1450:4001:811::2002	15169 (GOOGLE) (GOOGLE)
1	52.204.63.111 52.204.63.111	14618 (AMAZON-AES) (AMAZON-AES)
1	37.221.223.30 37.221.223.30	51514 (SPOTLER S...) (SPOTLER Spotler Network)
1	2606:4700:20:... 2606:4700:20::681a:cdc	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2600:9000:20e... 2600:9000:20eb:8000:2:53b2:240:93a1	16509 (AMAZON-02) (AMAZON-02)
4 4	2620:1ec:21::14 2620:1ec:21::14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	13.107.42.14 13.107.42.14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
4	2a00:1450:400... 2a00:1450:4001:806::2003	15169 (GOOGLE) (GOOGLE)
24	162.55.246.61 162.55.246.61	24940 (HETZNER-AS) (HETZNER-AS)
207	27

115 2606:4700:3108::ac42:2bbe (United States) 2 redirects

ASN13335 (CLOUDFLARENET, US)

www.europeanpharmaceuticalreview.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:808::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6812:acf (United States)

ASN13335 (CLOUDFLARENET, US)

maxcdn.bootstrapcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:e0::ac40:660b (United States)

ASN13335 (CLOUDFLARENET, US)

use.fontawesome.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:3965 (United States)

ASN13335 (CLOUDFLARENET, US)

static.cloudflareinsights.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:831::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2606:4700::6812:d73b (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.onesignal.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
onesignal.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
img.onesignal.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

7 2a00:1450:4001:803::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 51.140.49.131 (London, United Kingdom)

ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

secure.leadforensics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2606:4700::6811:180e (United States)

ASN13335 (CLOUDFLARENET, US)

cdnjs.cloudflare.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:80e::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82b::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googleoptimize.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:400c:c0c::9a (Brussels, Belgium)

ASN15169 (GOOGLE, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:831::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.gr	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 2a00:1450:4001:801::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2001:4860:4802:32::36 (United States)

ASN15169 (GOOGLE, US)

region1.analytics.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 37.221.223.17 (United Kingdom)

ASN51514 (SPOTLER Spotler Network, NL)
PTR: mail17.tgml2.co.uk

t.wowanalytics.co.uk	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a02:26f0:480:f::213:7ec6 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)

snap.licdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:811::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.204.63.111 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-52-204-63-111.compute-1.amazonaws.com

idx.liadm.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 37.221.223.30 (United Kingdom)

ASN51514 (SPOTLER Spotler Network, NL)
PTR: mail30.tgml2.co.uk

t.gatorleads.co.uk	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:20::681a:cdc (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.mathjax.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:20eb:8000:2:53b2:240:93a1 (United States)

ASN16509 (AMAZON-02, US)

cdn.linkedin.oribi.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2620:1ec:21::14 (United States) 4 redirects

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.107.42.14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px4.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:806::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

24 162.55.246.61 (Germany)

ASN24940 (HETZNER-AS, DE)
PTR: static.61.246.55.162.clients.your-server.de

servedbyadbutler.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
115	europeanpharmaceuticalreview.com 2 redirects www.europeanpharmaceuticalreview.com — Cisco Umbrella Rank: 648296	1 MB
24	servedbyadbutler.com servedbyadbutler.com — Cisco Umbrella Rank: 15030	2 MB
14	gstatic.com fonts.gstatic.com www.gstatic.com	613 KB
9	google.com www.google.com — Cisco Umbrella Rank: 2 region1.analytics.google.com — Cisco Umbrella Rank: 2541	51 KB
6	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 62	438 KB
6	onesignal.com cdn.onesignal.com — Cisco Umbrella Rank: 4086 onesignal.com — Cisco Umbrella Rank: 1292 img.onesignal.com — Cisco Umbrella Rank: 7527	93 KB
5	linkedin.com 4 redirects px.ads.linkedin.com — Cisco Umbrella Rank: 405 www.linkedin.com — Cisco Umbrella Rank: 636 px4.ads.linkedin.com — Cisco Umbrella Rank: 6338	5 KB
5	google.gr www.google.gr — Cisco Umbrella Rank: 20046	706 B
5	doubleclick.net stats.g.doubleclick.net — Cisco Umbrella Rank: 96 googleads.g.doubleclick.net — Cisco Umbrella Rank: 53	4 KB
4	cloudflare.com cdnjs.cloudflare.com — Cisco Umbrella Rank: 249	66 KB
4	google-analytics.com www.google-analytics.com — Cisco Umbrella Rank: 49	42 KB
3	googleapis.com fonts.googleapis.com — Cisco Umbrella Rank: 58	2 KB
2	licdn.com snap.licdn.com — Cisco Umbrella Rank: 909	9 KB
2	leadforensics.com secure.leadforensics.com — Cisco Umbrella Rank: 33716	11 KB
1	oribi.io cdn.linkedin.oribi.io — Cisco Umbrella Rank: 1139	373 B
1	mathjax.org cdn.mathjax.org — Cisco Umbrella Rank: 29163	2 KB
1	gatorleads.co.uk t.gatorleads.co.uk — Cisco Umbrella Rank: 75808	495 B
1	liadm.com idx.liadm.com — Cisco Umbrella Rank: 2721	209 B
1	wowanalytics.co.uk t.wowanalytics.co.uk — Cisco Umbrella Rank: 196649	7 KB
1	googleoptimize.com www.googleoptimize.com — Cisco Umbrella Rank: 1288	48 KB
1	cloudflareinsights.com static.cloudflareinsights.com — Cisco Umbrella Rank: 1103	7 KB
1	fontawesome.com use.fontawesome.com — Cisco Umbrella Rank: 1204	12 KB
1	bootstrapcdn.com maxcdn.bootstrapcdn.com — Cisco Umbrella Rank: 1134	7 KB
207	23

	Domain	Requested by
115	www.europeanpharmaceuticalreview.com	2 redirects www.europeanpharmaceuticalreview.com static.cloudflareinsights.com
24	servedbyadbutler.com	www.europeanpharmaceuticalreview.com servedbyadbutler.com
10	fonts.gstatic.com	fonts.googleapis.com www.google.com
7	www.google.com	www.europeanpharmaceuticalreview.com www.gstatic.com www.google.com
6	www.googletagmanager.com	www.europeanpharmaceuticalreview.com www.google-analytics.com www.googletagmanager.com www.googleoptimize.com
5	www.google.gr
4	www.gstatic.com	www.google.com www.gstatic.com
4	cdnjs.cloudflare.com	www.europeanpharmaceuticalreview.com cdnjs.cloudflare.com
4	www.google-analytics.com	www.europeanpharmaceuticalreview.com www.google-analytics.com www.googletagmanager.com
3	onesignal.com	cdn.onesignal.com
3	px.ads.linkedin.com	3 redirects
3	stats.g.doubleclick.net	www.google-analytics.com www.googletagmanager.com
3	fonts.googleapis.com	www.europeanpharmaceuticalreview.com
2	googleads.g.doubleclick.net	www.googletagmanager.com
2	snap.licdn.com	www.europeanpharmaceuticalreview.com snap.licdn.com
2	region1.analytics.google.com	www.googletagmanager.com
2	secure.leadforensics.com	www.europeanpharmaceuticalreview.com secure.leadforensics.com
2	cdn.onesignal.com	www.europeanpharmaceuticalreview.com cdn.onesignal.com
1	img.onesignal.com
1	px4.ads.linkedin.com
1	www.linkedin.com	1 redirects
1	cdn.linkedin.oribi.io	snap.licdn.com
1	cdn.mathjax.org	cdnjs.cloudflare.com
1	t.gatorleads.co.uk	t.wowanalytics.co.uk
1	idx.liadm.com	secure.leadforensics.com
1	t.wowanalytics.co.uk	www.europeanpharmaceuticalreview.com
1	www.googleoptimize.com	www.europeanpharmaceuticalreview.com
1	static.cloudflareinsights.com	www.europeanpharmaceuticalreview.com
1	use.fontawesome.com	www.europeanpharmaceuticalreview.com
1	maxcdn.bootstrapcdn.com	www.europeanpharmaceuticalreview.com
207	30

This site contains links to these domains. Also see Links.

Domain
servedbyadbutler.com
www.linkedin.com
www.facebook.com
twitter.com
feeds.feedburner.com
pharmaceutical.events
reddit.com
bufferapp.com
www.xing.com
share.flipboard.com
www.ovg.ox.ac.uk
www.bavarian-nordic.com
www.janssenpharmaceuticalsinc.com
www.russellpublishing.com
www.e-motivemedia.com

Subject Issuer	Validity	Valid
sni.cloudflaressl.com Cloudflare Inc ECC CA-3	`2023-04-18` - `2024-04-17`	a year	crt.sh
upload.video.google.com GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
use.fontawesome.com GTS CA 1P5	`2023-09-01` - `2023-11-30`	3 months	crt.sh
*.google-analytics.com GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
www.google.com GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
*.leadforensics.com Sectigo RSA Domain Validation Secure Server CA	`2022-11-17` - `2023-12-16`	a year	crt.sh
*.g.doubleclick.net GTS CA 1C3	`2023-08-07` - `2023-10-30`	3 months	crt.sh
*.google.gr GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
*.wowanalytics.co.uk R3	`2023-09-01` - `2023-11-30`	3 months	crt.sh
snap.licdn.com DigiCert SHA2 Secure Server CA	`2023-02-01` - `2024-01-31`	a year	crt.sh
*.liadm.com Amazon RSA 2048 M02	`2023-08-31` - `2024-09-28`	a year	crt.sh
*.gatorleads.co.uk R3	`2023-09-01` - `2023-11-30`	3 months	crt.sh
mathjax.org E1	`2023-09-03` - `2023-12-02`	3 months	crt.sh
*.google.com GTS CA 1C3	`2023-08-14` - `2023-11-06`	3 months	crt.sh
linkedin.oribi.io Amazon RSA 2048 M01	`2023-06-08` - `2024-07-07`	a year	crt.sh
servedbyadbutler.com Sectigo RSA Domain Validation Secure Server CA	`2023-09-06` - `2024-01-03`	4 months	crt.sh

This page contains 3 frames:

Primary Page: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
Frame ID: DF5DF7E69890F9312AC857F1108FA8E7
Requests: 196 HTTP requests in this frame

Frame: https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js
Frame ID: 219E1BA9C225ADA9FEF3FC4BB7ADDEA8
Requests: 4 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&co=aHR0cHM6Ly93d3cuZXVyb3BlYW5waGFybWFjZXV0aWNhbHJldmlldy5jb206NDQz&hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1&size=invisible&cb=xmyt06lwuv62
Frame ID: 5073347551D6A9B8B654AC158405B787
Requests: 8 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

Phase 2 study of MVA-BN-Filo and Ad26.ZEBOV starts

Detected technologies

WordPress (CMS) Expand

Overall confidence: 100%
Detected patterns

<link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
/wp-(?:content|includes)/

MathJax (JavaScript Graphics) Expand

Overall confidence: 100%
Detected patterns

([\d.]+)?/mathjax\.js

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css

Cloudflare Browser Insights (Analytics) Expand

Overall confidence: 100%
Detected patterns

static\.cloudflareinsights\.com/beacon(?:\.min)?\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
<link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

google-analytics\.com/(?:ga|urchin|analytics)\.js

Google Font API (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Google Optimize (A/B Testing) Expand

Overall confidence: 100%
Detected patterns

googleoptimize\.com/optimize\.js

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js
googletagmanager\.com/gtag/js

Linkedin Insight Tag (Analytics) Expand

Overall confidence: 100%
Detected patterns

snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

OneSignal (Marketing automation) Expand

Overall confidence: 100%
Detected patterns

cdn\.onesignal\.com

TrackJs (Analytics) Expand

Overall confidence: 100%
Detected patterns

tracker\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jQuery Migrate (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?

reCAPTCHA (Captchas) Expand

Overall confidence: 100%
Detected patterns

/recaptcha/api\.js

Page Statistics

207
Requests

99 %
HTTPS

78 %
IPv6

23
Domains

30
Subdomains

27
IPs

4
Countries

4405 kB
Transfer

8279 kB
Size

28
Cookies

28 Outgoing links

These are links going to different origins than the main page.

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2090645&setID=375052&channelID=0&CID=765340&banID=521037210&PID=0&textadID=0&tc=1&scheduleID=2015800&adSize=300x123&mt=1694025089679205&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=9666c746cbac8c0c007ebd695acc1e61584e8336&location=

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/european-pharmaceutical-review

Search URL Search Domain Scan URL

URL: https://www.facebook.com/EuropeanPharmaceuticalReview

Search URL Search Domain Scan URL

URL: https://twitter.com/PharmaReview

Search URL Search Domain Scan URL

URL: http://feeds.feedburner.com/EuropeanPharmaceuticalReview

Search URL Search Domain Scan URL

URL: https://pharmaceutical.events/the-future-of-bio-pharmaceutical-analysis-2023/
Title: The Future of Pharmaceutical Analysis 2023 (Online Summit)

Search URL Search Domain Scan URL

URL: https://pharmaceutical.events/innovating-cell-and-gene-therapy-qc-conference-2022/
Title: Innovating Cell & Gene Therapy Quality Control Conference 2022 (On demand)

Search URL Search Domain Scan URL

URL: https://pharmaceutical.events/the-future-of-bio-pharmaceutical-analysis-2022/
Title: The Future of Pharmaceutical Analysis 2022 (On-demand)

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2180773&setID=255245&channelID=0&CID=799570&banID=521317664&PID=0&textadID=0&tc=1&scheduleID=2103476&adSize=210x900&mt=1694025089679265&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=5a2e4c20c10fea06b2dfce8bfc768f18a98282b5&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2179160&setID=297599&channelID=0&CID=799060&banID=521314805&PID=0&textadID=0&tc=1&scheduleID=2101895&adSize=970x90&mt=1694025089681540&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=8af8e5d2cff17aedcc793b32c382a10d5f404831&location=

Search URL Search Domain Scan URL

URL: https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&t=Oxford+Vaccine+Group+initiates+Phase+2+study+of+Ebola+prime-boost+vaccine+regimen+combining+MVA-BN-Filo+and+Ad26.ZEBOV

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/shareArticle?mini=true&ro=true&trk=EasySocialShareButtons&title=Oxford+Vaccine+Group+initiates+Phase+2+study+of+Ebola+prime-boost+vaccine+regimen+combining+MVA-BN-Filo+and+Ad26.ZEBOV&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F

Search URL Search Domain Scan URL

URL: http://reddit.com/submit?url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&title=Oxford+Vaccine+Group+initiates+Phase+2+study+of+Ebola+prime-boost+vaccine+regimen+combining+MVA-BN-Filo+and+Ad26.ZEBOV

Search URL Search Domain Scan URL

URL: https://bufferapp.com/add?url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&text=Oxford+Vaccine+Group+initiates+Phase+2+study+of+Ebola+prime-boost+vaccine+regimen+combining+MVA-BN-Filo+and+Ad26.ZEBOV&via=&picture=&count=horizontal&source=button

Search URL Search Domain Scan URL

URL: https://www.xing.com/spi/shares/new?url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F

Search URL Search Domain Scan URL

URL: https://share.flipboard.com/bookmarklet/popout?url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&title=Oxford+Vaccine+Group+initiates+Phase+2+study+of+Ebola+prime-boost+vaccine+regimen+combining+MVA-BN-Filo+and+Ad26.ZEBOV

Search URL Search Domain Scan URL

URL: http://www.ovg.ox.ac.uk/
Title: Oxford Vaccine Group

Search URL Search Domain Scan URL

URL: http://www.bavarian-nordic.com/
Title: Bavarian Nordic

Search URL Search Domain Scan URL

URL: http://www.janssenpharmaceuticalsinc.com/
Title: Janssen’s

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2185146&setID=297597&channelID=0&CID=795503&banID=521295120&PID=0&textadID=0&tc=1&scheduleID=2107700&adSize=300x250&mt=1694025089678868&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=851af32865fb41c643c626074c233cbb3995b93a&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2185128&setID=203206&channelID=0&CID=796323&banID=521298381&PID=0&textadID=0&tc=1&scheduleID=2107682&adSize=300x250&mt=1694025089680568&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=469fa4268588b78950128fff3a5d2b4c61567f53&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2180561&setID=203205&channelID=0&CID=799490&banID=521317377&PID=0&textadID=0&tc=1&scheduleID=2103272&adSize=300x250&mt=1694025089679884&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=b7c0a530d7eec278e31842501351cd77113d90ea&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2169712&setID=297595&channelID=0&CID=795868&banID=521296429&PID=0&textadID=0&tc=1&scheduleID=2092598&adSize=300x250&mt=1694025089679144&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=a011a99f8e28f1ca59a56f906d6c0e70143b7086&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=1518662&setID=297598&channelID=0&CID=245807&banID=519597586&PID=0&textadID=0&tc=1&scheduleID=1468949&adSize=300x250&mt=1694025089683056&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=d3f9c28f68baeaaab0685276954ecc5c9a523fed&location=

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2180775&setID=255246&channelID=0&CID=799574&banID=521317665&PID=0&textadID=0&tc=1&scheduleID=2103478&adSize=210x900&mt=1694025089683267&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=a883bcc633d522404ff033be20b30247ac900b51&location=

Search URL Search Domain Scan URL

URL: http://www.russellpublishing.com/
Title: Russell Publishing Limited

Search URL Search Domain Scan URL

URL: http://www.e-motivemedia.com/
Title: Website development by e-Motive Media Limited

Search URL Search Domain Scan URL

URL: https://servedbyadbutler.com/redirect.spark?MID=167548&plid=2168670&setID=291841&channelID=0&CID=795533&banID=521295277&PID=0&textadID=0&tc=1&scheduleID=2091559&adSize=728x90&mt=1694025089678812&sw=1600&sh=1200&spr=1&referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hc=81ecd1bf34f83dd405dc836903bdd28434c771ea&location=

Search URL Search Domain Scan URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 107

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js HTTP 302
https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

Request Chain 151

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&cookiesTest=true HTTP 302
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D304042%26time%3D1694025089509%26url%3Dhttps%253A%252F%252Fwww.europeanpharmaceuticalreview.com%252Fnews%252F33350%252Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%252F%26cookiesTest%3Dtrue%26liSync%3Dtrue HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&cookiesTest=true&liSync=true HTTP 302
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&cookiesTest=true&liSync=true&e_ipv6=AQKbDK-Pf5IYNAAAAYprw4TfQDzuJh5_zJvUcrtwla7y4eTX09AyvzylnDF5JWfw

Request Chain 156

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js HTTP 302
https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

207 HTTP transactions
1 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2 200 Primary Request / Show response
www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/ 210 KB
39 KB 173ms
114ms Document
text/html 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

636d1daf62bd3e2585372b3c622928bd59080b9251b184e32f8483011103eced

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

cf-cache-status: DYNAMIC
cf-edge-cache: cache,platform=wordpress
cf-ray: 8028ca03c88b9b46-FRA
content-encoding: br
content-type: text/html; charset=UTF-8
date: Wed, 06 Sep 2023 18:31:28 GMT
link: <https://www.europeanpharmaceuticalreview.com/wp-json/>; rel="https://api.w.org/" <https://www.europeanpharmaceuticalreview.com/?p=33350>; rel=shortlink
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=0w%2Fxxg0LV69W4VxLlMxQH09fi4MNzSEuf%2BJ8jSQF6YQrOo%2FZyOvTVyELqqhAGrqiE21L81wwgNTxlMW%2BZrZvXUDkh2KpiivvivKhf5wJqkh3qpBYOA7dmBhnmy2zzoQUY99hY6qcTQBrhlIq2zHIy5X%2Fj9ldjMzsBwVrDVHoDLGkYg%3D%3D"}],"group":"cf-nel","max_age":604800}
server: cloudflare
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
x-litespeed-cache: hit
x-turbo-charged-by: LiteSpeed

GET
H2 200 css
fonts.googleapis.com/ 2 KB
874 B 49ms
18ms Stylesheet
text/css 2a00:1450:4001:808::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600&display=swap

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

f2276a18ac86fbba1d9887c34f938fcc98fed12d9a09b03fb5688988d750bb50

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:31:28 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Wed, 06 Sep 2023 18:31:28 GMT

GET
H2 200 css
fonts.googleapis.com/ 6 KB
611 B 59ms
29ms Stylesheet
text/css 2a00:1450:4001:808::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Muli:300,300i,400,400i,600&display=swap

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

0c737a04714a47dbf09c3ccb803aa43f0fc6d3fd0ffd70aaba05ff9580b63750

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:31:28 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Wed, 06 Sep 2023 18:31:28 GMT

GET
H2 200 font-awesome.min.css
maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/ 30 KB
7 KB 70ms
22ms Stylesheet
text/css 2606:4700::6812:acf
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:acf , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

799aeb25cc0373fdee0e1b1db7ad6c2f6a0e058dfadaa3379689f583213190bd

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: br
cdn-edgestorageid: 617
age: 19384250
cdn-cachedat: 2021-06-08 14:35:32
cdn-pullzone: 252412
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
last-modified: Mon, 25 Jan 2021 22:04:55 GMT
server: cloudflare
cdn-requestpullcode: 200
vary: Accept-Encoding
content-type: text/css; charset=utf-8
cdn-cache: HIT
access-control-allow-origin: *
cdn-uid: b1941f61-b576-4f40-80de-5677acb38f74
cache-control: public, max-age=31919000
cdn-requestid: a57ef3868a6dcb45c2e9dd28132f54b4
timing-allow-origin: *
cdn-requestcountrycode: US
cf-ray: 8028ca04d9ff9247-FRA
cdn-requestpullsuccess: True

GET
H2 200 style.css
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/ 55 KB
12 KB 41ms
22ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style.css?1693923522

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a7264081b33c946fb9232348c105505667dabc9c6d1f45a3716e1ed0a779e306

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 05 Sep 2023 14:18:42 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 99246
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=H9a5GreBrcQbXYm1Cd3%2FIGcBotwQID9R7IohWGWH%2BHPOndDSqwZFlX3mjDEPLeSNZ6fAxsxwa%2BwJXGCQ%2F9zt1H4NwnodFerO04NBZ7DT7XJgoUupOdmFX8YvrV%2Fi1fgAD9rtU7z8vQmqFB7JorRxxVnw%2BvgiHcHkSHdSczU7%2FFXepA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a97f9b46-FRA
expires: Tue, 12 Sep 2023 14:18:48 GMT

GET
H2 200 style-banners.css
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/ 4 KB
1 KB 41ms
23ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style-banners.css?62

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

916e414630f998f62d89b58f0e2f8262c33fe2d91e274f2a302b9a69b4c91e0c

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 18 Nov 2022 12:19:26 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=PgJliPY0LYsQFRi3B4ec6%2Fi7bvFjSp6wUM19ePLFJFDMB8PesclYXrctEnvbURY3RQTh%2Bq%2FFsuVLow0ilK9zPO7%2F%2B4Lo5Gw7uLKg6KJl9RaloN%2FlfjtUZABIuKLYzlRK7ZwaP0t47jyv6JQgWzeyZ%2BVgeXFSQNjgLpchqV5bTMGqXA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9809b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 forms.css
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/ 6 KB
2 KB 45ms
27ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/forms.css?35

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

204940afe9760586b383ef2b85e74853600ad372d219e0e5fab792531843f64a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 07 May 2021 10:54:48 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=yf2ledMachsNG6JKKr6yejo7pJZL%2BBsDrChTsdywjB75D3v5BVlJV7Kex8fuFxlcG%2BikLt7uL%2F6igjLBeLNspgOczyVauEGzdj%2B0CMpA8YXnwotqdS3aH4mxuD8maMIjE514PzQeLOOMSxAcVdnXtu0YuURVGGlWQkWhYIG5Ticjew%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9839b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 responsive.css
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/ 26 KB
4 KB 42ms
24ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/responsive.css?87

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e58980e660fd864229056443fc952d6f9e890eda03c1983ffd807d9c621a2e8f

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Mon, 05 Dec 2022 13:45:02 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=D8M4t0Nlb6Pgjgc5ofUa6lMlY%2BGRCtbm9tRuMbxIJ1dLteq0N3hTmpdBjUy4I%2F%2F2%2Bk244E0eoKsA6AnDDs5TvGTrOs923683DzfgYXlXGID15heVJoahNmPTQ%2BO6ArDc1hT1MGcfbJPSrnwHmhLuaPH8TB%2FRjbZhT%2BksBLGZ%2BEkXDA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9849b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 style-grid.css
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/ 21 B
391 B 44ms
27ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style-grid.css?38

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a6233fa56c20eaa849e341dbb3f778e8caee83d4fecae8fcafb2f1cb266bba87

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 119699
content-length: 21
last-modified: Fri, 19 Mar 2021 15:29:18 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Uo%2FHtOVYla6LFVpv44fZU0%2FfsmkVNQTKM6bkxXfk2%2FOkx%2Bc0oQgZS6pHL%2BXW8EOzxx0KR0VtyCe1lMzPOdeR6QQB%2FShJwpfA%2FeGwJD7CapvoKSBQs3LH6CrQPf%2BOh6ZrqMAYFWnoNK0eqQgeaABom5tEuI8sM3GnxV8s0kwJjescPQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca04a9859b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 frontend.css
www.europeanpharmaceuticalreview.com/zmember/app/webroot/css/ 15 KB
4 KB 40ms
24ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/zmember/app/webroot/css/frontend.css?12

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

58db26f0b52386b86a7d668b47bce73d1faaf9a0b8beb57069a63ba28f36c9af

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Thu, 04 Nov 2021 13:45:04 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ZqHoJYszhFzwo7AIAWOVvRhALXynlkkbtPN9hyZhsFdI%2FMy8XsK%2B0lspKQQ8U4eSpk2ER0fJFDYO5nRF9DCEWBpdIdCF1DDIEpsXU%2Bfm29RJB0LqeSbI8%2FVmNOF7OoGD1ZLwy%2BaqxTrdnAygV3IMGQBr%2FrpYE1LJ7icjX23NFMIDVw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9869b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 all.css
use.fontawesome.com/releases/v5.6.1/css/ 52 KB
12 KB 67ms
22ms Stylesheet
text/css 2606:4700:e0::ac40:660b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://use.fontawesome.com/releases/v5.6.1/css/all.css?ver=6.1.3
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:e0::ac40:660b , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 453893f7daa3d8fe9716f8c6d0f36f8ade8cacfc0093e164f4f998b46427959e

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
x-amz-request-id: TDHEV97TJQGSZG54
age: 1419798
alt-svc: h3=":443"; ma=86400
x-amz-id-2: HddRDnKdfxUBEvZWdd3z17P3PcFbf5cbBgHW/q6GbOOktbElvlJ3TyT9pkeJ/eXnGP/+mIxULfBQvbmrqVHZXA==
last-modified: Wed, 30 Jun 2021 15:44:12 GMT
server: cloudflare
etag: W/"b8085bf2c839791244bd95f56fb93c01"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IVVi851jn66CHi2frh1seN84fYcAHuh1Q6uOGygLhUtMTb9RpvU4yuz1kjJHqSuAf4WszLNwxeWCXSoeP7eBaEGFdydPwtKwlLK6U%2F25ngIjyQIprgziOICnOg3LLMUw2zisD7RAiemafKc%2FtPmEKR0J"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: max-age=31556926
cf-ray: 8028ca04d97e03f4-FRA

GET
H2 200 style.min.css
www.europeanpharmaceuticalreview.com/wp-includes/css/dist/block-library/ 93 KB
13 KB 39ms
25ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/css/dist/block-library/style.min.css?ver=6.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b041e7b08a99e947327a5faf96e5ab7aeef39a467c0ef2240710a19857743da3

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Sat, 20 May 2023 06:39:28 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AZsrg5hXZj7d%2FcYeh1%2BYQrhM73ZtxhmP1GI5%2BaJVBJnYA%2FKIAMqaFW8a09rABxuj7KxU29q5Bpu2F9CAQ51gyj5dbe8qsIlYLiPAmq%2F2rbQsuZM7HIpfCSjOfrErV5su8SwD58E3V3y1YyGMjjEy97kr3XVcbBPX3uajYY3%2B106NuQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9879b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 classic-themes.min.css
www.europeanpharmaceuticalreview.com/wp-includes/css/ 217 B
495 B 44ms
31ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/css/classic-themes.min.css?ver=1

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5a5f39391fbf5b06db84b8f9716d53de575ee97a627d2c5f12f79a991a671eb5

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:10 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120473
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bXQDiY%2BmVpU8z8pXIQ4EYW39Yi07iabRG%2FKFuGbV770LoNJC70wPEEOj1qMqCmkl5otCVRvMM1%2F7f0tpus7grEmFZjPWBDA59VHgenYxG92h4EQavR06hfCuK7UPobmULWFygc%2FGEQSrUk1FmOt8pCTdnbe%2B89akTx0LK9PVMpX6lg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9899b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 main.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/advanced-responsive-video-embedder/build/ 1 KB
774 B 37ms
24ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/advanced-responsive-video-embedder/build/main.css?ver=70807f607880d07700da

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

028b3be727cbed0ee4e0c9a67c5a1991d8997ca97ecfbf830c448cb7730e22df

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:36:26 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=one%2F7xf1z57fG7mQzOKRIEVl3xe56R5aBp6256IsJyLojZZCDMJQJwWXK29LANe6CgAcmpaiNLKEhLVd%2BcyFVBSAgWUFbE3aBOUv%2FlI7YGH8aUbAhmvDDBjd%2BsdSZkpKb05Hg%2F4RZsKlpcU%2Bhju4ZytZI7FB%2FmOLUxZNPVY0eFZiFQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a98a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 main.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/arve-pro/build/ 7 KB
3 KB 39ms
26ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/arve-pro/build/main.css?ver=b235eb33eb28cd4cc3a4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

52f1242ce4333ced64463347687a7280e2ac3d2e4f4cd340b9fcaabe73761af1

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:36:58 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=GjJO4vJVewDeecLAJs84cd7r7W1fDYQ%2B4KJQwD7py9MRzw9i8yO7ev1dz1SsEPks9x0H1gkzjftzzP9o9hQcRB9I6ikV7zl5r757zYQy4u36FTkuGbvgR8qHpMlToQMxZXiN3BitxtKhw38ns6mOw4j5S0Edhk2CFBlPS50o9LtKFA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a98b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 wpcf7-redirect-script-frontend-css.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7-redirection-pro/assets/css/ 252 B
429 B 51ms
38ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7-redirection-pro/assets/css/wpcf7-redirect-script-frontend-css.min.css?ver=6.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6eae212fd161b7b43204e54fc106f36b0bd6b373762af8074d7e843b5a4a08eb

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 01 Sep 2020 20:50:32 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AAEk7inwvNPfKAB1EC099mhJ98Q5GvgQprMCCn8Akbu2uDI8Q0KXRyR8dR7%2Bey2clHY0x37s8ZxmgDJHOmN%2FFWF%2FuFQSofdkdk76bT4dkFX8%2BiehClnttvzUzT9%2Fic%2F%2B6d4BZ4ZFeZwMNvFzgw6KcxFQYY9PC%2FCaeza0hZPQE7hxbw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9909b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 styles.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/css/ 3 KB
1 KB 41ms
28ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/css/styles.css?ver=5.7.4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ab21762c3f447aa08cbefd5ea3866165f925bd5058a9ae19e23721462de6fb60

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:36 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RtpiaoRKyKhNiL0xHwjgnDJA8OgrOF9eUrLh1Z%2FfNMSfIhDJEwq%2FtWuxGzvbjCUSckFIni%2B8N8bow6PIxEO1tDAzDXB820%2FhHr%2F3RJpJgUVcMQxPR4Q6ZpjK98f7Q8DI7u6KqGyzbXHPg4SnJWbSX1yPAGggsTsX6vZyxMY1x7rziA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9919b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 styles.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/libs/fontastic/ 5 KB
1 KB 64ms
51ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/libs/fontastic/styles.css?ver=3.0.34

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

578332cd14c1c8f1c9ea7cc966ca50ae73945b7de3055e07f06dc099d4feeee0

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:55 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120473
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=3Evwr%2FR%2BX%2BFSr2rMOH7tFiTsj%2FcgV13SND4uCbKIwv%2Bk3rzzWpKUuVcWWuZNrehxZmuJTBXh2LogA4ahAjeIayrDbA3PEdC96z%2FqVaz1tyqq35ra9UtW0VQasT9bPr%2BCYmK1f58bMbdcPeozCizg66n5xXI5VZqZaueWb%2BixkwAT1w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9939b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 style.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/css/ 10 KB
2 KB 49ms
37ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/css/style.css?ver=3.0.34

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e19a0e64789068d756a1b250084e54bb0ef77da66685e3dd9eafdc9a71ea1406

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:55 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bclcxjhHmSJMJdVyD7HOa%2B9KIFUjmDOxB3fBQ76JAyvTjWMeGBHcY%2FOaxlI3uvwP4sRkYIr%2FLA3QcRioVyt8vrWYPFCxpjv8%2BVacAftJrkRCdWZ1Weui3eI3eW2T%2F2rtWgzrt3jQLcRgPJe15xmdIfwp05eCgqggJ6L4YTTVQnjTsg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9959b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 ditty.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ 34 KB
6 KB 62ms
50ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ditty.css?ver=3.0.34

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8f74e61d48c9e52b3c8d1bcdad624fe6c872bf718db48c52eb3009619bb6a606

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=9WChBhg6oAWE1kdasAxMI0sRGwbWJlEdWs5DEsr0Uon1hFPMkGqxZQOP2DEpJR7umlo%2F3mBomXJIRJlbhQsw%2BSXXJy1PbI4t3oDhStcQQCvR85aj3VcELAyJ5Zkuh80frbPYYlRXNs%2FUG5S1T%2BmuRyq95%2FU2yNxALMjKYARs5B4lxw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9969b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 ditty-displays.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ 5 KB
1 KB 46ms
34ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ditty-displays.css?ver=3.0.34

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f2f3090410eabc60e4d5ea0683ecf04ed48d018cf4f9e32521d8aa5ea4193fbd

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=s60nNeWILJVviv8PuwTxmDLY1cztNcRrGkjTWPCb6XTAK84xZqsSL2dCSH8w2N5nodj8URlmuB5Q1zqF4YyAPr1vc5PZDdz%2FFUZTalmQ7EG7kr5DmAVPHReTWvxe1jRFl6SL0UOaIXX7EVpyxSPaYlQWkDVoF4xofscw13wbos9DIw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9989b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 all.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/ 136 KB
24 KB 47ms
35ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/all.css?ver=6.2.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

83c5ebd47131aa8aeef9d7ace04d313c997b67934791fa92c366e78e99242329

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=yUSE%2BcV%2FAHwtX%2FeaRumeB2R6zmosICq44vuGnxn%2BJNnYTfZmklf3iDEUZvU0FkKNgFpDOOH1L4lw8EyOi7SSxulNeOQkCc9MOz80uKIBpivXuaMi6bGx4oXY3HFFNwMrOYEd5rtud2hL5iZSKUdYVvUAn8CHt4KVZru7KunGATX%2Fvw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a99a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 ditty-editor.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ 13 KB
3 KB 43ms
32ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/includes/css/ditty-editor.css?ver=3.0.34

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

54d15b2e78fa2ccedc59339be094ad2dc7cde526b05c8365ce661b695f59cb16

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=XVP07aXE7HaLS2A%2FMDMT%2BuNXeS8W8amYFhqlTbjkpgSpl9tURjla6CwZooMHxSL1ASgJuajwC79kd%2BXIZTYKf%2BirQoh8Gkh2lsJ8PyB9dV7F1NoZO9sJE%2BP7LdCjg1ME8USEiTTno1N2lucF%2Bbit09fpZTetzxjPbnQhQJWHdVdXww%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a99b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 events-manager.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager/includes/css/ 206 KB
38 KB 69ms
58ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager/includes/css/events-manager.min.css?ver=6.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

66a9e43130da041760046dff8d3a2d021fa45a1d24811a7bf6642ea46bfd9047

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:52 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=tPsAJsX9Hs9hwCLMs28nY6C%2F2DnvyrTUD3%2FZtU4OtOfMHh3sggSPhPLxjnxQsqkM0tXYVKf3f6mjie47FADNzPrv5S26UxZvXmDnc%2FFG56Pq2aAgahMA25O%2F%2BRsMGVCzYDs2ltgYPl%2B5GCA0kR1cT%2BiDn0OpMHWOd5FJDJ9661L30w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a99d9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 events-manager-pro.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager-pro/includes/css/ 3 KB
1 KB 48ms
36ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager-pro/includes/css/events-manager-pro.css?ver=3.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

09633800cece83fb2340dca614d3089892ead37c8a535cee4519995d7340d167

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:41:34 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=u12Pr6WFmZv2mXEJVRKf8HsXDZIqefFD4son7H09uCYQmETEyeWyMUVFIxQ7B45PeWbAWF0qT7ZHnWIOz%2B9BpqRzv3qDy29UPz6cMNo1C9L7bvkyG53Ie8ggDkpoiYIhqOMdUSqzzp5RFc%2BqXLNpunOcuz2LJVbl64h1SUFCpiKFsw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a99f9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 geotarget-public.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/css/ 16 KB
2 KB 58ms
48ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/css/geotarget-public.css?ver=1.3.6.1

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

303a3183beb25d87b4b551609af6d46c4c5743b5fcd01f73469a4d70a224dbb0

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 07:08:42 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=58z%2BYsULaw5NLH2MmL44QWVw96XQEW%2B%2BHTj1t5tVoDH49Uq1GP5VXj6Dh2zQU%2Boo0t39z9RaIBn8b5MJF7ni6ihX3JSi%2F1XSKROHvjPCZsP5XdWYN0UTNaCtKLJJmSIFX5mTRWAaScBuD4Xjzyc7DmG6juL%2FDzM%2BxrkFTNpQ95dsrA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a19b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 cookie-law-info-public.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/ 4 KB
2 KB 48ms
39ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/cookie-law-info-public.css?ver=2.4.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9e0206d7fbd04e129433b165f9d6eb325fb64d93d0320c39c0c1a2aa0af9ecd7

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:43:50 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120473
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AVuYHc7Cw3GX3Waa7DJ8zHbFFwx23fGwLKgHTrKmyxxxlNdH25c2ey9D7nwDQsIajb%2BGpZ3IZvxdcPfzXZiIwzF1rRjayxoYWc99Mb8m984rywpsABfyjOKbzudJeZda8Pdz5%2FJ9iWfI3djjbT4xh69s%2BZeJi%2BoAV4S0StMMW0Mv0g%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a39b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 cookie-law-info-gdpr.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/ 22 KB
5 KB 46ms
37ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/cookie-law-info-gdpr.css?ver=2.4.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b426c235ad88e21d669aaf6226c60c196d041c6e74e507443af32d6541d55f4a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:43:50 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=eZ5TAEoKOa3aBpxIR%2FTLqzmQHANt%2FabrSqKduezhmV%2BJhqvXreeHMwNk8cecwWVnObSWcLtEmk%2BdX0NY73Fkf4sNL3tfn8d7V8cVUakAjSxj142MVRky9opkdQZl4MbKU9zYmdXzKiqirZj8HGRgPOwYwLHkdWfBULI%2F10xLSOJbtw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a59b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 wpa-style.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/css/ 5 KB
2 KB 64ms
54ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/css/wpa-style.css?ver=1.7.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

13031d4ec04980984b56e9152739c608e15fcda23007e524117198f054385eb6

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:48:49 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=YZdxHydlM6EB5Uol5oSDkFzqPc0Y4pe%2FhQexDqajFsJ73g0qoAFokW%2FT%2FuG9saBBwGyDI%2B74U2%2BzgV7p5GtjswKl4FZhbp3G5qzWWmhTDqLtWWDW2v2BjySQqjQcwVBgafWv8BA09iTRc8XPMFk%2Fql%2BQ2NqO3yWbHO86mc37iKaphw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a69b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 twitter-feed.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-to-twitter/css/ 2 KB
838 B 54ms
45ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-to-twitter/css/twitter-feed.css?ver=6.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

196b0d1013a5fb1985890e13453ab76df8bdcee3d57893e84afa3f3e58eacf52

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 07:18:44 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ZaJ%2Bs36tuno1%2BknXup5sX45K2nLYnN2IJ3XHMXJrHy%2BlVBQv3rTXrtHSPqiGLOEJXsiC%2FZYoxr7rnL%2FslmcmQnmi37eRndylsXADPp58J4KLiG2YiJgP%2FCrpznHsWk5lzLYGEivT0csvJYQSjOF%2FePQaOmM2dkUBwaIDfb1ceozz%2BQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a79b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 subscribe-forms.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/ 23 KB
3 KB 58ms
49ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/subscribe-forms.min.css?ver=8.8

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

bdbf202cd096103d51142548fbc224c54daec112d86dc4fd4a1bd123dddc9927

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qMGpKRKGIm5eHMmiipjC39YwauCXM%2BmPy87YSAfxBrjO8sGy3%2B9HniGD8RrVm0Bk%2FOrOINVkB8DF9cbgB2Xcc7Tv9WlPeeJoM0T1Vkw%2BRiwCx5BOA7shXUVzC2A5HgNOnnGtXfsEEtcWc9TPA7rZ0oBj7I06X8ID82JUn1vHr7cjXg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a89b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 click-to-tweet.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/ 3 KB
1005 B 42ms
34ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/click-to-tweet.min.css?ver=8.8

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc15061d8c788e977befdf83b405f229f96556c3fb1c31e18958a66f20754f0d

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=LIlbrNDd9ZW8e6nfXn1JDjmqlMp0h%2BR9Pqm7ks%2FUw%2F16lurMF3Xcf%2F303bZgHkuz0o8ChmoD0gttIuZuXmv7wEelexHw6p87NHwMLthAlrBBWrnl7MLXJ2EXeztLSvWjE0YQTb1JHZId31HPfHGoSo98kY90QmPKPKScLIHpbNRlWQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9a99b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 easy-social-share-buttons.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/css/ 71 KB
11 KB 55ms
47ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/css/easy-social-share-buttons.min.css?ver=8.8

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

442a93bc4ed53ff731192cbbba04a75d370ff795faca04d06b2aaa83afd1b48a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1NFsvdK4xA04snAVmqJyMZsLmHAkd5US5W8MrGqur16KZZl373iO%2B8F5nVyccHxLlaLTC5UOdZZ%2Bm%2B%2FUOsNMDs03%2B31DvwPZvHPvkQJ18PONoD1MuPLBRrqgD1jslRAx4MV2iYEQftNtyZ2B1TS%2FyoxVVEbOFfbtRb%2Bn7vzoE7Jddw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9ab9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 style.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-posts-ticker/legacy/assets/css/ 314 B
512 B 62ms
54ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-posts-ticker/legacy/assets/css/style.css?ver=3.0.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9e832759eb73e07aa5cb8d9f961625d2c4e5903de4e5ee34cbd413c0338d790d

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Mon, 11 Apr 2022 06:21:25 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=LaKmO46TDX3WlbF6nDy0sOYi7e2%2Bu1%2FD0ODeMD6VMeXShzBZMt4MUw6OGnOMHDB1izeYK8jwOs3l5fQxgVsMwmcj%2Bihgw%2FD%2F8e7GOncO2jSLl1%2BLbRolBO19NpqwfysZw%2BhWM4OpMjMxJAiPhkCY7uQk5TfPpK%2FduHXwfViRg3mPQQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9ad9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 style.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/cf7-conditional-fields/ 2 KB
833 B 63ms
55ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/cf7-conditional-fields/style.css?ver=2.3.4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

cedc9155263d1f634191e71f3c9ce256b315f833e375739ed0e65087996428cc

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:04 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=HoQ8hcrGWHstHM8B9z5a8XzcVp%2B9hIsahpLcfGGDKH1NbXw0zCr9iaxobPM6H%2BUYbfKxeLwMBNWaSIHTc%2FyJ8Rnvx%2BprrFLfN%2Ffplbe0szwONZ%2Bi311HE9p6rxpbSuW6awGcHTGu1gYX2iEpe4t3HS2bNcgp%2FS4AvgHxeSeGVHTa4w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9ae9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 ubermenu.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/pro/assets/css/ 45 KB
7 KB 55ms
47ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/pro/assets/css/ubermenu.min.css?ver=3.2.7

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

23134fb54459872d99152d55ffa65a9e6858bdb4fa6ed262f727f4dc78c4e19b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Thu, 08 Jun 2017 11:49:18 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nXbd1uzDXugw%2BK4WFNYJlxdWuVjRXiguri5I2zgBNrMgg04xMoEuhRh4zyBSwaiId2s3Muo%2BC7xnYIYc05AcI8v7AL7UGhB4WGGYi4urEc4XD%2B3vqfqoOD6ippWXbwcLcSaq5XLx88hxOyN0xuSL0OJ7POuI2vXs%2FFCMBQ6rIvTIPQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9af9b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 blackwhite.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/skins/ 4 KB
1 KB 61ms
53ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/skins/blackwhite.css?ver=6.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

89851c36a6269b4cde4732f7ae4daa688596d4a822603b6af86d361fc11f4771

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Thu, 08 Jun 2017 11:48:14 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mpEgxCMx4Ww1JvGxUUFDNeZV4hmgpayZj31ktPKB8QHFurw9XyXwTkMPiKLqO8P5s3tT0L%2F5FeLaTiFDYWdpJ77dL2PhMuSlAh%2BJKqIqa6E5ess8zHHKneyPTCVER77HdFDyUffjNuZ1pgpdjYFjoyYway%2FZWz51GnTk6aF%2FS2b84w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9b09b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 font-awesome.min.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/css/ 30 KB
7 KB 57ms
50ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/css/font-awesome.min.css?ver=4.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

799aeb25cc0373fdee0e1b1db7ad6c2f6a0e058dfadaa3379689f583213190bd

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Thu, 08 Jun 2017 11:48:00 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=NiUpYFzDlCQtZfK3FTcQ%2FVVLk65vvC1AZ2mTETNXVqIoFHOSKT2DavrWTQ%2FVRdAG17%2BQ%2Bbz%2FKOhQugiQLeDG0%2B7ewBArt3qnyByYbFDakgGHUVxmUgYE2Ok6v4gPpzMy255g8SzJpLsAa4REfH764v1VgyqelaOrw0ZlrwZuJP1%2Brg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9b29b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 custom.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/custom/ 3 KB
925 B 53ms
46ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/custom/custom.css?ver=3.2.7

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

479d0d0dc75842e56660bc544203c45f12c9efd8c598f66f494dcca691a3d24e

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 02 Aug 2019 13:04:56 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UimdT0FgDVxwcX%2FcmNgQwCP0gcS0UfnLz%2F08mqB%2BDAav0RzkZNxM%2FxFxE7e3tpsva2eEv%2FPgLo8FGjMcsXk4IcD49xVtk1ZWYYwCBHHGjTHZ9E63uOlyyel7XiDtgfvqEwRY7HvfQGkBjQxdodMrYTlWKY3Uc4KYegxSqYTXB8%2B7ig%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9b39b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 email-decode.min.js Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/ 1 KB
1 KB 35ms
29ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 04 Sep 2023 08:31:24 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
etag: W/"64f595dc-4d7"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nkYSvyQKjQ981%2B5yKGec7ARc1zaQnh%2FS9UyPzaK18tJGW7zcka2UMfZJTCK5KBSuCuOROp%2FDqTLUV4RSxzPOE%2FWtIOXmdBw3SaTMdfFv1TpbeIYYkrCb2vdDL%2BVahIJJbfernr4qC03sIw0oXwFaUsZ3xFZEAi0vaeYf9hry3N8NFw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
x-frame-options: DENY
cache-control: max-age=172800, public
cf-ray: 8028ca04a9b59b46-FRA
expires: Fri, 08 Sep 2023 18:31:28 GMT

GET
H2 200 cookie-law-info-table.css
www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/ 6 KB
2 KB 60ms
53ms Stylesheet
text/css 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/css/cookie-law-info-table.css?ver=2.4.0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5fb5f7b54d71a8ac603fceec9e2a6560c59dcea9ea178ffb165546cb185f21cc

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:43:50 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qoVoaawd4LAsmYnX5mPtD8TN6079sADMKfaYKBstdaM6x5jN0m16PpX1iG36ySitzIGi9JWmcILUnfZK1ntPpMg60eAVp2cxDzkBstJhGFEprm2Yh82mscszILIzfkBIP%2B8QFlP7TgALgSnGq37Tdis1ldiN93PL%2BjxDdrPIViSb9g%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca04a9b49b46-FRA
expires: Tue, 12 Sep 2023 09:00:25 GMT

GET
H2 200 rocket-loader.min.js Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/ 12 KB
4 KB 11ms
10ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ccf00d1923b0131a10e0c6d26f95e5dee6ebf8621a27e83c5a2f68a2e0093142

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 04 Sep 2023 08:31:24 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
etag: W/"64f595dc-302c"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=QS6On3P913S4iwbKWk3Na%2Be8Vr76E5ATBCWdZZ7gzXT5npkF%2BNGawaMEpHuDoY9MELo7hHbAkWL0fcc0pkcZt9KMQKHcNvPhOGFtPN6l3%2FOM0iSusmiYg%2FzEMx14AE7B0kYEFY5uphe%2B8a%2BF6nv3lLoGqHKhnlfTTTffgMax4rXlJg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
x-frame-options: DENY
cache-control: max-age=172800, public
cf-ray: 8028ca050a309b46-FRA
expires: Fri, 08 Sep 2023 18:31:28 GMT

GET
H2 200 v8b253dfea2ab4077af8c6f58422dfbfd1689876627854 Show response
static.cloudflareinsights.com/beacon.min.js/ 20 KB
7 KB 87ms
67ms Script
text/javascript 2606:4700::6810:3965
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://static.cloudflareinsights.com/beacon.min.js/v8b253dfea2ab4077af8c6f58422dfbfd1689876627854
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6810:3965 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: c235f21017bcc11fcaa31d7dfd9855aaebcbf5f6d7ee9bf9f2e98a910907c391

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: gzip
last-modified: Thu, 20 Jul 2023 18:10:27 GMT
server: cloudflare
etag: W/"2023.7.1"
vary: Accept-Encoding
content-type: text/javascript;charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=86400
cross-origin-resource-policy: cross-origin
cf-ray: 8028ca052bc5bc03-FRA

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 52 KB
21 KB 36ms
7ms Script
text/javascript 2a00:1450:4001:831::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
date: Wed, 06 Sep 2023 17:49:43 GMT
last-modified: Mon, 12 Jun 2023 18:23:07 GMT
server: Golfe2
age: 2505
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=7200
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 20994
expires: Wed, 06 Sep 2023 19:49:43 GMT

GET
DATA 200
OK truncated
/ 35 B
0 Image
image/gif

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 04c1bc744720c6e7542613e933c9a0f4bbd8f6ed45a5b1924223c256430dfd7b

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

Content-Type: image/gif

GET
H2 200 searchIcon.png
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/ 262 B
789 B 22ms
22ms Image
image/webp 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/searchIcon.png

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style.css?1693923522

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

bd57bc6badafb2b490f765fd705fa2d53896f040e7b4b538bb70456ec97644cf

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style.css?1693923522
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 10168
cf-polished: origFmt=png, origSize=1303
content-disposition: inline; filename="searchIcon.webp"
content-length: 262
cf-bgj: imgq:100,h2pri
last-modified: Fri, 02 Aug 2019 13:03:28 GMT
server: cloudflare
vary: Accept
x-frame-options: SAMEORIGIN
content-type: image/webp
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=FaO%2Fk%2FW5XzzOzS8RmfMtThXWyNX7UK0f%2BjVDvekT2eZxDTI%2BZYzlsBvHkqxnMBgeyJv5eJj9ybwsMZREfS0ld%2F7H5BdAPmYholF2Qft7KDuk1biMCInfhyo8r5SCl1uyXV1ZcnCV9oRsgOOOT98Da0x0lX6m6KosgnfzbA2J1VDuIQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca054a7e9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 rp-logo.png
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/ 464 B
858 B 34ms
32ms Image
image/webp 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/rp-logo.png

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style.css?1693923522

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6021dc6db79a633312d6f152c30e36ee6f2f42d1c087b7bfc3b7cff887949009

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/style.css?1693923522
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 118886
cf-polished: origFmt=png, origSize=1865
content-disposition: inline; filename="rp-logo.webp"
content-length: 464
cf-bgj: imgq:100,h2pri
last-modified: Fri, 02 Aug 2019 13:03:27 GMT
server: cloudflare
vary: Accept
x-frame-options: SAMEORIGIN
content-type: image/webp
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=jY2htc3wNirt2QyK969k2XpcOaX73%2BPln3PZ36EGazTws3Ow8kkS8xInhmCWClsvnI3xLOtDyoBa3tWGbJFy0%2BFK0NF74wwTyvq56iWMgKTG55fGtxmc%2FeJeoXo5ttYZBqzI42Pxg3EJxN0ko4%2B%2BMYPFJpIeS5ASMZOWNTZ1xtTlvw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca055a9b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 fa-brands-400.woff2
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/webfonts/ 105 KB
105 KB 23ms
21ms Font
font/woff2 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/webfonts/fa-brands-400.woff2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/all.css?ver=6.2.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3fe890d088ecf0cc9bc1b9069201e52972dbad6237865524090e15982d0de718

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/all.css?ver=6.2.0
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 119699
content-length: 107460
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xCjVaW0bFYCEBAKp2KcTgHQcCbzvkMDHg8UCcCJzUdzleDSEcx7%2B8flYknBd373mQz9gpsXHLDxb2jbvWhQG%2BZcYw0FcsNJpYhUqI%2BCrEGoLotoFMNLqYINRofOopPcjXIQsFik%2B02TAQYB69BH7%2BpmzhL5P6v5MP8DrKRW%2FjRF8Rw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: font/woff2
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca055a949b46-FRA
expires: Tue, 12 Sep 2023 09:00:35 GMT

GET
H2 200 fa-solid-900.woff2
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/webfonts/ 147 KB
147 KB 26ms
24ms Font
font/woff2 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/webfonts/fa-solid-900.woff2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/all.css?ver=6.2.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d27bc752105c079f8a516e9142406a9fc12cbb409f9bf8681f2ddfe0360b52a6

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker//includes/libs/fontawesome-6.2.0/css/all.css?ver=6.2.0
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 120472
content-length: 150472
last-modified: Tue, 07 Mar 2023 17:01:56 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=H%2BfHTtYLqEkWFfnD1HwBHwr9N9z5OoycxNClZQlO4a86uqdU7li6w4y2pZq6j3ZIcxEukWsIY9AX1dxvK%2B1UvaJPi1pf30OQ9zQ21jOJ9z%2B44nJMAuCvJB6XP5iS7bbKCDSfGFrwr1d0cs4hJpw6J2bA2C4NzCTTGDHki7Mi4aBW9g%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: font/woff2
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca055a969b46-FRA
expires: Tue, 12 Sep 2023 09:00:35 GMT

GET
H2 200 fontawesome-webfont.woff2
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/fonts/ 75 KB
76 KB 29ms
28ms Font
font/woff2 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/fonts/fontawesome-webfont.woff2?v=4.7.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/css/font-awesome.min.css?ver=4.3

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/css/fontawesome/css/font-awesome.min.css?ver=4.3
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 119699
content-length: 77160
last-modified: Thu, 08 Jun 2017 11:48:05 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Jjdju4eGJINWu7ed8i05UDNIw0TUfI%2FE%2FCjKqHLH9vDBJoRWACRxA85vPG00HP%2B4974DEGLAie49tze6z63NkMu9gTj9dxIZJ8xdAeUhsE7fdA6BuQmpqZccBuIf8zFniry1GhfN4k2a3EzRp6mu4GmTw0WVb%2FF4tNrTY89CQHuPow%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: font/woff2
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca055a979b46-FRA
expires: Tue, 12 Sep 2023 09:00:35 GMT

GET
H2 200 essb.woff
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/fonts/ 16 KB
17 KB 24ms
24ms Font
font/woff 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/fonts/essb.woff

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/css/easy-social-share-buttons.min.css?ver=8.8

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1cd82d0cdc1913fa55a51736475fd9ff3f392c5c19e92186b94b370be719c5c9

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/css/easy-social-share-buttons.min.css?ver=8.8
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 119699
content-length: 16684
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=eamwmsKNKxVL8emOz%2FRAJuLtaFg0dm92HSdcb%2Bvzc1fBZQfF7AwqFzYyN4x%2FeCBE%2FYGJz3voGeTfaONpes30UasGbWWl1jmleQEyp82VC7RSeh%2BaP1BP4YNyweeF0onj2h64tZg5X9Em%2BVMchaZRTaDHMT0BfqYkz%2FN1L1jFZKPdmQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: font/woff
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca055a999b46-FRA
expires: Tue, 12 Sep 2023 09:00:36 GMT

GET
H2 200 OneSignalSDK.js Show response
cdn.onesignal.com/sdks/ 9 KB
3 KB 381ms
21ms Script
application/javascript 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.onesignal.com/sdks/OneSignalSDK.js?ver=6.1.3

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c0d7eace6de7a123701ad163455f50ea9f6f51c5985a49f4d1f6e797009fbdb1

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 1967
etag: W/"2a3bbde818bef34d53a0df862ead5d5f"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=259200
cf-ray: 8028ca080c6a5c98-FRA
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Sat, 09 Sep 2023 18:31:29 GMT

GET
H2 200 longdesc.button.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/js/ 3 KB
1 KB 48ms
34ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/js/longdesc.button.js?ver=1.7.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

05c78d6a2624f38e659dfad31d402bbda31897361e2ea1a4ef04bd1e78d41b85

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:48:49 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=gWpG1CbJAEBBxt%2BrIUnd3nSH0UNpevbEenqt3B2oRouo5LK8clUfY5d0khT4r1R59dboKwzAWINVvAU1FDkiosRzvdOqd2Qu6IFfNq5%2FKIfFDCBp4jOkyBpBI2gs9oy%2BH2V5Jgz6Hu72vSySK9kb27Owa20kfikSfrCjz5R4xv%2BgMg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db2a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 wp-accessibility.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/js/ 11 KB
3 KB 48ms
32ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/wp-accessibility/js/wp-accessibility.js?ver=1.7.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

88a7f2522dd8c93c1f5007fcbcd059cff32a895cdab67e4d0398e94e950fbb65

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:48:49 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=8EWgwYZ1WYaQKhNhWrQulqbBWxxxNOstwuxbpjrjQy31TqFupRczMqJlw9l7%2Fv1NSsl9oVYa5cd5eCTy6vpc3PVDbwadSUq4ZkhNNgaBVUJ4D11ZBp3qXumGqXlK5QPC2pUO9n7yRdufS5ujivbY6GItWD%2FLQx64qe%2FAoEUMqMrUsw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db2e9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 ubermenu.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/js/ 28 KB
8 KB 49ms
33ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ubermenu/assets/js/ubermenu.min.js?ver=3.2.7

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e81ed9b95f47aba3ebc923849774acef379dfb142c47f4208e733c3283e867c0

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Thu, 08 Jun 2017 11:48:19 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=brbapF7l9iwgare2PKRSMMS2vjFEErOHTF80FICAZBhf6Nrb8QLOd%2BVStZ%2BMxJ02DUYZesVOrHH%2BxHc4KfTttmcCTpN04%2FBjBazGRwUp2pP0L1eJPUIPWA%2FVg%2FNnp3SZbNE5Mw1t7XXi3dhyHKR09Df1d0WT81h6rtjZzBit1PLA9w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db309b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 index.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/modules/recaptcha/ 999 B
934 B 46ms
31ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js?ver=5.7.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2648a1333fa24d383fd73a6beaac17156ae78f4267ff7407ad60e05a788df44c

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:36 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=h5hcjTIvAjyrQ1Kk2JOg4%2BuMI8mFRr0gGPqcAfMsmp9Xh68xwFEW7U8dnoexoOxu6kLIhFEEr%2BFA7Y%2FRBBil9czf5c1YVlx9TtVNs8%2FzLIQ2PEnsvVxrviGU2ZBmZg0EH0t8QoK9lQJL3%2FjUddw3aYpo21VbldJAUdcmNfvWeEVUgQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db319b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 wp-polyfill.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/dist/vendor/ 17 KB
7 KB 46ms
33ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/dist/vendor/wp-polyfill.min.js?ver=3.15.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1c1fef6e6b4f9832603850b9b6562e74d9a6a3700ba836efe88facc577121e8b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:09 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qMU4%2BSuczPxyUJHdqA9i6MCwnm9vPs9SKv4hazrc3HBDCYxdpST%2FBc5f45ZYK9AYiL5vv8iCBgSDvxkrbNLDBVxn2eAfFX00a0RUZpUEbZYwb9zLwljm1iH1no7HJMImpsodYtZkgDiLrNQpNpAXI4HtGV%2BU4sJmaw1AuU5L80Uvxw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db329b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 regenerator-runtime.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/dist/vendor/ 6 KB
3 KB 48ms
35ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/dist/vendor/regenerator-runtime.min.js?ver=0.13.9

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f30769ea0b80a5d900c5f0de30b1aad1ab461195e69223d5ef63c2c5de8b6c1a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 03 Aug 2022 11:32:35 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=w7A3JKQmVukA5gwVLJCWFfy4w5lisKZStC2QthV9aVUq4DcaMlT13t71jDQptObGS%2FxjeL1UnrCOmrZ9tLs%2F6bnBPF78HqPrvMiOQ6JejG1EdbnbEVlyRlMwHVfHjk59UOK6kr5jb3SoqAD5QHyejs48DTwAavjMWddvJ1tHx%2F5RXw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db349b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 api.js Show response
www.google.com/recaptcha/ 1 KB
1 KB 103ms
21ms Script
text/javascript 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api.js?render=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&ver=3.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

72531dc7cd31356b74af7404cd355296fe63fff689ceef1ca2f7bc3081c728ba

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 863
x-xss-protection: 1; mode=block
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 scripts.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/cf7-conditional-fields/js/ 136 KB
33 KB 54ms
42ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/cf7-conditional-fields/js/scripts.js?ver=2.3.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7c77990bc88d4b4834ee62a3ceb8da90c2e24be3d1b44209b6404d1865b99217

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:04 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=YpABW3OItwExgW6DukW738K25rMiMWzhqsLYAC6I2LsJcBfXPS%2FCT6CFvmQHdChrCx6Rju5Yhra3vNntpDECuMRFrJqRWLZ4Z6FMvyUhK5e3%2BjVR8%2FCOsC6LrUOe1z7tTlTVrlCo5Ip3aVk0b5CE1WDpbjTDwRGvVg64ftQ8H%2FI3%2Fg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db359b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 688.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/ 1 KB
769 B 54ms
45ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/688.js?ver=2.4.5

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0c9aca2a71cdfe5e8e4eeed187dc802909e67482e63d1c3642d75e9f3067c8e7

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=tZmLkSKOgsddEQxBdiH%2FmOB7tKG2lFxvz8N8D2%2FBb3ngRDsbj6P3hURQcXuZLm7wU3i744PqsX42nVOCXNxkxMYzaJyDQYPSuBoDqtfZA87YwQQm9XiuMXQLXaPzyB4alDnaL4drndiIk3Rp8lBvARTvw50Ify%2FKx8k8YHFjNZL72A%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db369b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 599.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/ 4 KB
2 KB 70ms
61ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/599.js?ver=2.4.5

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

045623753f6ec51bc4797e3d69d3b23459bd4447bb16c994e56454fef1488c66

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=WR%2FG5DZdU4XruGE4X3UNyOidW0quEm%2BmSxJ2pYCoELIy9FCouuZXUZtWnpDTImZOVmOtrjpdp0xViufzfQDu2tfPXLteldOO0pPCgmnjDUSwGhKydfd5%2Fb6Xjn6%2FL%2Fu4Zp9s1416DlDJ0u87H5pmARGcW2OLDq49QOI3RlXgldxlVg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db379b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 292.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/ 10 KB
3 KB 43ms
34ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/729/public/assets/js/29/292.js?ver=2.4.5

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

622d4e2da39f5ea961864441f76065bb203bb9053bc3f03c256f42fc5ab1b57b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qnDvyfvEvzF%2FyR21tL%2Bmx5TwXVybsecQUNXv7NOB2mVFGGAnDjhsj8G1ISsRstAmp%2FtF26Tpv1YaLhpjYCGiFkz5vIvNzqG%2FWbdkyRqvWG%2BunNOKgcWp6AT0zVt8vxpOT0jyb%2F3%2BRPCHHJ2nvyjPIxOzdYHoh1CoHamkblO1BDAAug%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db389b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 new-tab.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/page-links-to/dist/ 24 KB
9 KB 50ms
41ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/page-links-to/dist/new-tab.js?ver=3.3.6

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d455ab882af3a742e6c9680578e6a590681bda99e34847f550f1f41a7d167969

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Mon, 10 Jan 2022 07:59:05 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nEHvVwe5u2U%2FqDZRVGOefPsEUf%2BEH5sm%2BhL5PgfPbbSGaB6rN1cs0UTKt1kvcrd8wTo2I4itqhq7s2TYe5jBFiyq1Ziarz93L3etO50siIn%2BYFJDo7oM3cFO9U%2FsPdzvO21H%2BdHCa1I9ZRMTBDKule%2BAu6ZQyhSS1WwJwPEXFqgIIw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db399b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 999.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/assets/js/ 6 KB
2 KB 47ms
38ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/assets/js/999.js?ver=2.21.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0ba2a0da5c4bbb91065d70e8d6e9e22b1eb1c2e066ac876e261efcc96036b031

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RP0L6GneD7AEmBv69rrjaFE3o%2BsnUUqoz4eOidxwi6qWf0pznScVhsLDLjik9%2BHn86S1PMusYAfB%2Bwjx2o2LM91%2FWNymVTqmeptve9TJZU1jikpSIwu8cyzhpABZJtkLZqH77CYud%2BvM%2FtxvC31Py1A2puGuvVtxX8auPPPDNzowIw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 856.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/48/public/assets/js/ 6 KB
2 KB 48ms
40ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/48/public/assets/js/856.js?ver=1.8.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d8503c041e7f21942aa95fcd5992a29989cb49116d3cb3bf096455658498417a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 29 Apr 2022 06:36:26 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=F7QhTJJmaznaUtQ7zUR4593SwTgBXN3J0yQ46utv2IOFTAaA7pkZL61p8a287dOEj9iBmq0fyrxSzMFMqxkazPGNtQDY0%2B0qLLnBAO7%2FVAz71mtRcu1EaE%2FJqCac%2FtHsVxXx5trzw%2BZYlunQr2eYi8QcIEBe2UBiG8xAHu6OFRH2HA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 422.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/137/public/assets/js/ 3 KB
1 KB 43ms
34ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/137/public/assets/js/422.js?ver=1.11.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5841eb6d1895c740317d98a4cd9e5aeced865f5c50182647401afc3d303367e1

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=MWw24sOz87n5TRtD8lWjbVjvH2GoBSS3Ob6HcuSp7rezd2c2w%2Fg5QRZiv5wyn3uVew7zUTgnqyWWfgEwcx2jyiy3PGPYSMmFydzIPotgX4MIHS157qy1cB3jIlQh7%2BM5DzIQM0bfvdDdf2PD%2Bm8lVlfU07dtr%2BapnQzU1%2BuQGFnsUw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3c9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 357.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/829/public/assets/js/ 27 KB
7 KB 43ms
35ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/829/public/assets/js/357.js?ver=1.7.7

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3a86cdada5e5a31807176f2881b5b196dedbec52d01a47865d9ccbf6f8e33f23

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=GW5cOeFjGtHeyptEIFA97qmCQBKITwYGZysgY75DYK80xRLHINb9LuDWTcuOeQ%2BdmdDYKRtSkPc9lqpYgDvcBPuKyAkF%2B3g3qm63atD%2BLphECeT6OI6ZX%2FR4t0fd%2FaUa6Id8V4tQb5hv3V6UB2CYqkiXKsVAqwavzk8V4%2FiwGShGLA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3d9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 573.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/assets/js/ 72 KB
24 KB 69ms
61ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/assets/js/573.js?ver=2.21.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

07556f378e5523136e2c6e0197ed545fa18f9f7022c83a93eac10ea24533bcfa

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=0WcKhIZbuS5gD9jvzZYA8LrVHi10sx0USa%2Bu0pV1DMzlgBYH2eRQw8Z7LRyBq1K5Lbfe0RX9EMQgIzQXACZzaAu1t2yOF6faCV%2BHulpXBgwbwbSxMvOq9%2FiFA4DDU0i2vjccP3CsDlqgOBGUob6vuU22zgB0odlTDI4Vbfq2z7GCIw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3e9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 top-10-tracker.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/top-10/includes/js/ 286 B
584 B 52ms
44ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/top-10/includes/js/top-10-tracker.min.js?ver=3.2.5

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d0a77e495359613dd0f75850a9b9a541f059b6f215c76acddb418bedb7a2cf6b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:02:37 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=puyV6yPESfLSjpA7h2t7Nl9W5bxAzVTjwsDe7jc3IKLzrbMR1uG4kWM%2BLgI9U4qiHRFsH%2FBK0p5nGPbuYPDcv63IRSJdkB8HUD2iGOx38OrD0MT7ReNaN1SnUIsNROHwh6%2FH%2FJLiZialPQ%2FBtgIJpumR4qNwFZmyAskCzid1XISvdQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db3f9b46-FRA
expires: Tue, 12 Sep 2023 09:00:38 GMT

GET
H2 200 ditty-news-ticker.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/js/ 14 KB
3 KB 53ms
44ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/js/ditty-news-ticker.min.js?ver=3.0.34

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9808e9a37df4741d8a212c739cae654d1e935e3d3f9251c9eef6be7bb24b1eab

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:55 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=sKl3Lvofn3FxRSWZpd%2FLxEgrilrSgeWDb2opca44Jyu%2B%2B%2BAFwn1c3OmkY8FNra0mngsOvH2COkqneqobSzn2Aej%2B28yMqtU0oE5fiGgWj6Mfh8i9DhLhnOvOSLmb%2BQ%2BNOL2JyuBEAKjkE0R0F2d9DqYDhXcouwRwvLAGhsF%2F2WxTuA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db419b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 effect.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 17 KB
7 KB 56ms
48ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/effect.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4471f0e0712693e37d562bb4981a7da17248062fc39140f3df05826943879fb7

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=fvIuoNkmQPP1PoDLTRl8F0pR3Z3V1Jz7sXOWghCoVu2DFEtDzRFty11CMlgxDLfaT8gFSOw4uJcP1%2BEn989I8S9lEcmWK0QC8%2B5f2YemG%2FCIDERzsTQB9zuwpjsv0Z5JEteE1vucnBc%2B7BZ9bu3LSJtQTTqulG8QIAwalQ5gX%2BP0Kw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db439b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 imagesloaded.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/ 5 KB
2 KB 45ms
37ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/imagesloaded.min.js?ver=4.1.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ff4bd34aa98a0214833619d3d751838db015722dfbbec15cd14dadc66cd67869

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 01 Sep 2020 20:47:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IUFkPr8ijVhorEqQLtE1ZfbZAs0R97pYKxxygcQtd8%2FsDYcGYES7H%2FqV8ObdGZZ022Y9NrYIGZt1nyXKsanpAwxlsiwEB0UTvqd6p8R4IunEAXV8eFtakFPlJahcEsbVfihlcm%2FX2VW%2BywZulNTGHJPKB8L5L5dTmW41djxGUw0iBA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db449b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 swiped-events.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/js/ 2 KB
1 KB 50ms
42ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/ditty-news-ticker/legacy/inc/static/js/swiped-events.min.js?ver=1.1.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

db0fe819895d07af230d0f21f183ae4c9ecdec27664f004c6ac8844deaf55adc

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 07 Mar 2023 17:01:55 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=LrQKTRGG5rZH9ROJ3ZVDLLvhKAWkDuVS8jpgmQmc49u628Jv6AzgGevy0h4wOMlGr5bFc9BcVnXuunDm2WIsC2hUmGK3plPZ5LM%2FifVicJ2gTnPzJIW1oBf0OTdfrHDaHc%2Bj0HD1gIIwm9YnbJPSzS3GeYHgnCSLfx%2FAMhfqRVPXNA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db459b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 index.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/js/ 13 KB
4 KB 47ms
39ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/js/index.js?ver=5.7.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8bac631dfefdb96cf5526520c21e9ef3f585bba973970a7e62b10c945741105c

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:36 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UKt3SlZrenHIoAwzhHgjuR8PsWqQTfKD%2FBWr8pN437QOogdD1PMN6fgxBPmA5KOmHLLRZwKvqm9CSb%2F%2BBlix9IYbGubsJU4ojlrYIzMq%2FVC%2BBFFV6Vr%2FLymFW%2FZHGJKWNR5NLMwZYd%2F%2BJU%2FGXwt%2F7kzoZ1JwXwJx3qsbIxD%2Buskjew%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05db489b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 index.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/swv/js/ 10 KB
3 KB 55ms
47ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js?ver=5.7.4

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

23bb39b607b39a93d953762d2a618a3cbc69c52ceaf70d96890137ca1d2b0228

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:38:36 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=MPm%2Bae%2BPSf7rfW3A5GGrxkYIakTQqRz5H7gOMWK2pke9kEtOIsZ9eB6Y5CKv5LqROQiafd3oc8O198EJWjK%2Fbu3ySpkU7Zc2CgBe7itRzpT8g9oIiVhPWdkflXSLA0LePflg04engpviDtR0kHoBXU7rqhNiLTmTyrYVZNz6Yk0TIw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb549b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 wpcf7-redirect-frontend-script.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7-redirection-pro/assets/js/ 7 KB
2 KB 57ms
49ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/contact-form-7-redirection-pro/assets/js/wpcf7-redirect-frontend-script.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ebe74dcd5581784a9d1d1d3346e7b1423d054c32689efa4ebc1b2c904f85a233

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Tue, 01 Sep 2020 20:50:32 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=pJ5rqMMlgaRYPosQXUGAy2Gqm2K1aqBw1uI4kRx7i40U2oAUgYMRFSdvr1NtBWqBsWl3Oz1fMBO%2B%2Bmj3JZQFum0bskPLRkY3FAc%2B3szbm8u0C23UNYlcXOtWIUX5B%2FsNgxDTfqnkgTe7aejad%2B1L6n5RPGcDrpGnXnA5IZ%2FmJ9qkkg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb579b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H/1.1 200
OK 223774.js Show response
secure.leadforensics.com/js/ 23 KB
11 KB 221ms
23ms Script
text/javascript 51.140.49.131
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to

Full URL: https://secure.leadforensics.com/js/223774.js
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 51.140.49.131 London, United Kingdom, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: a57dbc8a722b9e87f5cec63cb0b3a3df697edf62499a807deda579a667d63486

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

Expires: 0
Pragma: no-cache
Date: Wed, 06 Sep 2023 18:31:28 GMT
Content-Encoding: br
Transfer-Encoding: chunked
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: no-store, must-revalidate
Request-Context: appId=cid-v1:abe8a76f-f1a2-4b2e-9017-0ea36ffb5c20

GET
H2 200 random_order.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 2 KB
1 KB 53ms
46ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/random_order.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d70cefeb3756aa26506147fe2a965b8f3c438cc1536ca3095c4575735be1686a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 02 Aug 2019 13:03:31 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=9tBCXSmczfGxgsq%2FTq3UfHbgQLFbfyNrciXdaj4f%2BF2U1%2FcAq3NdEcU%2F9Sp1bysI7wEQUcYXEoFDpKpZKXN2bLKkmQ9ELcdIqQAZb6vUDVcD%2BRu7F3FVRBPz1tY4vDT5SbT%2Bv0GXFepbACMcr4IPeLIVMWjhdnAw5TaTgN%2BLLR3%2Blg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb589b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 hide_empty_facets.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 314 B
521 B 63ms
56ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/hide_empty_facets.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3d16a5a4e863b0910ad953b325725fdb82cf8a8055db033e9925cf255b8551ad

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 02 Aug 2019 13:03:30 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=wL1M8FmgNNjYn9Izn8cON2aW4o2iHoJrAU2GrMWhk5TmCSRUQWgY3qpBTEzNDnWmVjyuuL8eNweZakeFb1Bhd%2F%2FTOOHGZfhToOTH1tRL9VDFB2BHVkh8TMyNc%2BSdhBgeqRBIWy8%2Bnd%2BPILlAYRfxNLGkjd7P%2BPIZfDIChGS0ZXVLPw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb5a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 facet_scroller.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 181 B
572 B 75ms
68ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/facet_scroller.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7d3c7c58e0a4fbc40dae789bebe500a3d0d837f43df558f52af1052c4936f82c

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 02 Aug 2019 13:03:29 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=v1ikVn8kpJIz3MJMfh%2FyBNd4OfLF0vfEoo2VPNVz1P%2FaXV3VI0mRJcDMrwFwwTU%2BdtLMP%2BXRyQZwxBxDYy9FjR%2FOxQinxwHaybNEkhTGvgaKMgIgUZuGOJKDa9IWBOK6ay0%2FPyQR63m3zs%2F0A26H9EPWyZw9NOlW8PJUKfPf%2BpVOJw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb5b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 toggle_view8.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 617 B
591 B 54ms
47ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/toggle_view8.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

279a4286b060df1ef8d319db605518469c2f221633e99328cdac27a895fcdf7b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 19 Mar 2021 16:56:31 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=PZttPOMCtqwpmy%2B569BPZ%2BXrQBScHtrppooHytGd1KiA8kuSiM8npFc8vpEBzrfwwfI10GHo7O8WX3%2BqrtoWZwdfLcXIzz%2FR7EE3fd%2FpvchIcgTwJIGNQDbjocfzd6EvinqjtOpqjHqlnzz6nRXLxR46X2p5Zi5IsObupuF6fMtfLA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb5c9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 MathJax.js Show response
cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/ 62 KB
17 KB 297ms
23ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=MML_HTMLorMML

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c987e781b10abf844435f183bcd52a253a8615c29fdf534911ef4e4e79cc1f76

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 2054136
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 16903
last-modified: Thu, 22 Jun 2023 11:08:44 GMT
server: cloudflare
cf-cdnjs-via: cfworker/r2
etag: "64942bbc-4207"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=kC%2FtoK2SlLJcp%2FZn12t50pEVryfhAvVhUxv44%2B9YpRXzlUr6b6dcXv27YlORSb0hyx2h5NRgFrSAiL4kM4FujLUbOasr5qy4QJzCBu6Pzi5VxfAcN8mM41EDKlIwvWBihS7g0I42zlJWuWvMi4dSKS%2Bz"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 8028ca078adbbbf7-FRA
expires: Mon, 26 Aug 2024 18:31:29 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 194 KB
70 KB 299ms
22ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-964653157

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

400338a215884d3cdd5345fc80e7b77f76bec4b0ec779de8730e958b7c578f1c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 71748
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 722.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/412/869/213/ 1 KB
797 B 61ms
54ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/263/412/869/213/722.js?ver=2.21.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5a095d43a6cb207c855ca0b8d70d314f6454e5358b1cf4cf2e9dae378e33e3c3

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Eg4nUspJC6VjBJzqF0qHW7RImDV8n%2F4O4FowLWb37APE23aa6SFB1FB%2FSG0McjO8qujb7n5mP2%2F0ohYRiOBxeJO7w%2BIXBI391f7z%2B7EFPXdNWyGVzpzENIAhWYwVppfkAKEjG6OAvXvKzRgTc0%2BG4%2BxZNOvKq19E18ZX40O7T2p37A%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb5e9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 128.js Show response
www.europeanpharmaceuticalreview.com/wp-content/uploads/330/963/public/assets/js/ 7 KB
3 KB 67ms
60ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/330/963/public/assets/js/128.js?ver=1.41.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1a4dd11c3764a3be7caee75eeb660be2d9f01fc3ba61f95990d8f64e5e441875

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:53:13 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=K8%2F8xfCKg9fEOf4Vw1ycPDaJmpY6pgEoKrGn6UdCr1kNkPYBWAtFLM2wU7rs%2BWcO4Ac9buDZn7mi%2BpADja%2BI%2F4EfIBr5cEnqFAbofTzQ%2FSO1urRIsfNBrKA4yuAvixBNt5VJspx6h5s4USxW2wQp85EGt89FjbuPrLQ0dZ1dQ8RS8A%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb5f9b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 cookie-law-info-public.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/js/ 50 KB
13 KB 57ms
51ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/webtoffee-gdpr-cookie-consent/public/js/cookie-law-info-public.js?ver=2.4.0

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5fbce8a3467310e80aee477992c4ace2a0492cf074eb7bd808fbc54f1b32841f

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:43:50 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1Gjaf2MdWHAMKPQ03Li%2BAyTAN%2B%2FYEaABIB3kchiFFMcxHLPLX705rbYLUYl6nTBL%2FCqj%2Fr%2BVBLW5Ev4pHp1%2BMJ6pSUdgh%2FKhoq4lHA6r1v1sHX3q%2Fm4LvknVwTYWG5Z0Uajel3ejQBje5pam7H39G8yuV7ouGFZQfsP%2BLTDy353hUw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb609b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 ddslick.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/js/ 13 KB
4 KB 55ms
49ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/js/ddslick.js?ver=1.3.6.1

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9d2e812a4b7d908811b4498cfa2a5b02fc04f974f3fc1fe41187b298a395776b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 07:08:42 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=JPgOonZuODFwv%2By%2B0eUqTf7vsZdcnKJNE2nvzptaWbTO%2BcxaMtDKlR8Ov4IX4JU7k6VX7HncGL%2Fwd%2FxWsPpTDnCaUaEknRoYnJbgZKqdwXwURp4oGm5eoLaGQs4anBZ3raMArtLUbg2AXjETBfwQUP9xKrGvxRAu9vKL9qZU7WKBDw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb629b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 geotarget-public.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/js/ 957 B
823 B 56ms
50ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/geotargeting/public/js/geotarget-public.js?ver=1.3.6.1

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b0ca3abdfbab847952c45c3a8f2f583be363263f54d8b34ad1604de0278191e2

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 07:08:42 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=79cWVFV2WgAtB5Is5qX2Dyy20WYaUiqJqGhiyEHg8wR481k55TQKC2jg%2BnNzL5L9ah8JL%2FEzTVbtTzlYrkqIl5rEv4NcgN3hVuN4ssaCh%2FWq23oxjyOmsGqJayIXw12MvlkX2Pd6Z%2FROarFmVSG3UVzlM2xbBImi6PouqfSBxoHijw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb649b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 events-manager-pro.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager-pro/includes/js/ 2 KB
1 KB 64ms
58ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager-pro/includes/js/events-manager-pro.js?ver=3.1.3

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

882bf461f27b3300b442ffdef8f95ecae78d562ad63e686182fd06b558d00c66

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:41:34 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bmhrSrH4A%2F1caMJBBOx2%2BXskkM2OUnAP%2FGR8wcv6fVsKEA6rhBpEMctY5vmi1ekZapFdLl9PkD1Ex2IalDfrLqxyyI8uZnp5H07eCazaej0QUbuDGezG7XxROnJ%2FtsgUEsiFI1PT%2B44I8iWmv5IreEP69N%2FSNjEsOHRQloohIEsWwQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb679b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 events-manager.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager/includes/js/ 312 KB
86 KB 65ms
59ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/events-manager/includes/js/events-manager.js?ver=6.3

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3eb2861edb732eb23c1000b154b8fcb87a47320fe43b815911379ff3f26f60db

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:52 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=QOrDXuhJRt6AVTEgBHplzVVQNm6TwzGwBV58jhxH71WQoUu2LT%2Fp2vC9EaJ6gXN3Gc1XuXqutnm%2F3tdhlYl6YkDPeb2kBMJ1XghKRszj8zieAnq6DJIAA2CWLaxAr2nG%2BHlyxs84S67401YgMZ3xse5pYWz5JMqa40X9cvn%2FnF4H7w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb689b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 dialog.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 13 KB
4 KB 59ms
53ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/dialog.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

afa9c32be463f8f904da58a52ffdd8e60d68273959cae633bd89efbb27fa5b64

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Xmx%2BjZphuO6IKot%2FKXMC1ycrQXVj2dQE%2BvfTDr6cNwWGuv5%2FDX6VvGoj8KArWQI%2BsA5FLfdkgWsm%2BO66EOdW%2Fkk1yWwrCiri6GLS45YGs5rkQXYQvW6UW%2Fn1yyuxqQ9yXhq%2F8H1atIwxuLJjezFxjh4kDpxtZeSCaEUX6uPOE76J8w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb699b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 button.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 6 KB
2 KB 62ms
56ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/button.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2793a7736c4421efb5ec1f639c9b19a081a6b7a91097d4459149fab67c47b9ae

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BKWCSYPKA%2FfUemDcs83eBb1Z5fBa3d0n6D6quX4ppSmLGt%2BDdmE8vBobx2E7hyyjeta4K74H%2FaaqTPCQrsy7RPkYbay152OzURqnD2FVf23JmjKr4q%2BiIk67cRj8TyxdlNbwguZdabTFyyIqBkt%2Fawmnw66DQWbkxGeTVw8xE3o2cw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb6a9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 checkboxradio.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 4 KB
2 KB 58ms
52ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/checkboxradio.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e2f925db6119917230e885b016055a6a324d33b10585d5c7f106665ec157754e

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=hKHNhjkHZtXxS971QJq%2F3D%2F9UFGbdT2xDAkc8Z6JEeGMEookepdmYUZGR5J%2Fs%2FlJkSU3%2BPh99E9sm%2FS6RZhtGJxiQyKbeMlxy86AdeTIJmxo3C2pIdLkeE11fi8SQXYUZB%2Fkkt5cRuGNIOih2jshug9iqTG%2F5bZfPZP60FmyNDjMOw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb6c9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 controlgroup.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 4 KB
2 KB 57ms
52ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/controlgroup.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

da343c70bf28bee6a1a9238dd5147b190b675a523e525e9a52b2bd9aaf48e4e1

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=OVAdIf8mejQHj0qTAiDwmzkoduRbzb6zar8Xf4iGVgTOIz9Eh5wL83fCskogRk3qBumqFR0%2FYnI5hjvyE%2Bu8%2FWS3de2Es9BJZq%2Fi8RisL6GWXlVdSL8MBJbvXj4AKEiwNHvjoZzc%2FiIY7LXjVAhie9hsE7U%2BxGn3AZnUtNkSHfN3fg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb6d9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 draggable.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 18 KB
5 KB 57ms
51ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/draggable.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f7cea32499cc55e5232ec287c438644afef28297f4248958ee32906dd34ae5f8

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2BpRwHWvhvAkO4nRplt0kj6qos3k7dpvzsVj3rJW5TivdwquPO1ynlQZ7LovtSrPjYCqfrLyEl15HzegVNfnGx18r%2B6dIFjL0ewdKRvRANLW3ipoRkB54ltSEBfcYrVzCLjyn3eM0Wfo8qqXJ2oFWJyvMnaGIPctTYqHR5G48ocTscg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb6e9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 resizable.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 18 KB
6 KB 60ms
55ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/resizable.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

706e4d8669d29a9e13cfb13a59b6c1341ec80a08c9c10eaa465756366006f327

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UEwC98YoOHC4ySsR%2FVx6Hv%2BEVQd69lQITNAzUku7qVId5m4iSNwHxO8lUxqiU9szJTx%2Fdr3rxh9%2BGB773%2BxmDMZksuhoqjAy3tqaP%2FIRBfBnF3qCIFMg0Krspe7jqyuIXNfi5ers4U8zw0W9XdYZwn0ojHOsujpLV%2FbnXkwYHv3%2FBw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb6f9b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 datepicker.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 36 KB
11 KB 59ms
54ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/datepicker.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8821cd10861112ac07254592b0b332abd02cfb6ac32c0ac71378be0fb58c309f

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=0NJF6fxGB4J3qPczcFujnyVKI6FAFXbm2NcfjOP627KioRQhXIFhx1R5DgF%2BczLJAPU7BeBnK1JUOMjA9XxXjBR4SK6RrBcK%2BXeznZhWa04pe0Oy2s%2B31uvGPY0deXsrJwWuVOXT4qbj3W9TEiZglwKWnuKfssR%2FCjOeilOhtgG8QA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb709b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 sortable.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 25 KB
7 KB 62ms
57ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/sortable.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

59848acc8f86a05b6983df9f54056ec156e969186ac5ac2b723b57303143bc7b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Y9yEtoFAK5gDiQXVb1My7djFfux%2BEWXpXnl7Ra0%2BGmtXXAYofjooA6m2Yx8iq3jNZWaLHgzPICCmRcEMHB2PP%2FsVFGL5Kw0g5WbmkyYewG8hiinHw77CaOKVxt6RiKm1uH%2FAL8Euy9b%2Fluqvtr5sctTztOKRTWHbZYjjJ1cJH30J%2FQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb719b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 mouse.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 3 KB
1 KB 57ms
52ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/mouse.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

809ec973a018b6bf8ac18e74bfffc3d25182e6f44df00128d531cf3e07570ee6

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vzmslmZUc%2BytnXTtUxsQ8JwgWNysU54PONTdXcE1KKTBHRkYF%2BZFNEO1eMKvFsQcWnwVZaTKcfC7giqBhiX1ROBVd192XRNZiKLLpqV6mRV5%2BaXSWL5A3N7ZsAXsSNo1y4Ovp8uvsWvyInL3dWxxisnXkP0iyCV0fhUImQUQSmASwA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb729b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 core.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/ 21 KB
7 KB 60ms
55ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ui/core.min.js?ver=1.13.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ca7154cdda62b535ceaba9ad2a2b2217ff49de94c069a2c4e89733f3f06b3651

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:08 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=5sALrX3EuCeatAyk%2Bj8xo6K2GI%2B9Wc2T%2Br6ZLAT18Q%2BrfyCObxK2RDgZC8MULHCnvRkxBjC4%2BwcUFOmtTXVSnC3G7B6D4lsPf5vBI0G9EdFY9X9Gfhq3VwUeE3IQia4w92UT5%2BTucR%2Fr6WkFfEFOMYCnOQg7f5mkvd6N59WIE%2FXExw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb739b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 jquery-migrate.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ 11 KB
5 KB 58ms
53ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.3.2

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

029e0a2e809fd6b5dbe76abe8b7a74936be306c9a8c27c814c4d44aa54623300

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 18 Dec 2020 12:57:35 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=OmJPj%2FXkwWB9aXxn%2B0Tbm8F5QjMq%2Bmt1EN%2BBDv1ROB9FfIcZcgaxY2LfKS%2F5K3picE0oLSmVAyffFL1ZA3%2FUJ8Nh%2F%2BiCAA572Ckeo420trh0bUdLx91wyHP0JZ%2BEAXIrEjB%2Fz0iEkNtR06s16NS09HtcjQRv3ZqSTUh13zpy2m8PNw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb749b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 jquery.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/ 88 KB
32 KB 61ms
56ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.1

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

cc7403bab52ed166e24ea9324241045af370be482f5b594468f4a6ac6e7e7981

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 07 Dec 2022 06:54:09 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=705rt5igloNlk0YaBX1qDiW0YwmhUUm0GVdg6pUOVplNEFEa73QB8DyPs%2BVgaSkvzE2i0oUw2RtMtO4lDa5vyweQz2ZaCqQM1iK3o8GqOZNGY4NQsLn5C7Ue%2BvzjAUftGdBxy%2BqrH1qUW6JgYj3DeP9gAXiCUaS4yDbfXcKUUSiVBQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb759b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 main.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/advanced-responsive-video-embedder/build/ 1 KB
921 B 60ms
55ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/advanced-responsive-video-embedder/build/main.js?ver=70807f607880d07700da

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6d68efd39e7462337c72fb7e3ceb57eaed7fd0ef9f952d8a5f48f78361c299ef

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:36:26 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120471
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=4Ohq96KBNdGM28eozuPXOw%2FMdUD%2BkKc6TmKHXpFDtLfLVU1S5f6iUm5Q5Gr5%2BQmUn4PFxK6nu1vkAfDbkE0xXRYjPJ2R%2BdQyZUtAkZgjZB6qcF1TZerAJFOdXuqFuiEdhGCJmipUKvBjnKtbZPCak5gQO%2FvY70LVckulrJF6bQFRvQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb779b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 wallpaper8.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 407 B
567 B 57ms
53ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/wallpaper8.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b1fb822e7c6fe10be230ba2bfcca03b9b8169e9e43aa3b1a5fcefda12e04ec6a

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 03 Mar 2021 10:39:59 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=deBnuhPz1Sl2rVv3VvoiRUx2VzBAGBmJETnWLWu7JVvrm6nYek8yvk6jCLeDrIJPgoqyFWTfzt66jpIlGw7r5RCNv0CIv6TuIYeKm5nrkmCZhGwkcMMwx71n8hlp2EcNgoET8nhUA%2B2e0sE%2BldbA6hHtRoo7nTRyYplMCY%2FflSPpxA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb789b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 term_more13.js Show response
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/ 485 B
563 B 62ms
58ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/js/term_more13.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

54169b42e428d60f4cc305c5006e0883e193dc636054a49eb2d51f1641289646

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Fri, 07 May 2021 10:47:07 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=fNCeIq9b7n%2B%2F83ATgp%2F2ZafsyJWv54fs8hMEWW2Vdsv1zsfEDghXzxHQFSCwVwKTvad7NS9%2FsSHLp%2FIrni25ZOQ7hQh7JtxrX1FgFaJGYuzPajvweEmYOehSOr%2FgrTdZr99nTp6lvuWTnOXVbEW36IRfa9dN7AJLankwkWDqD9DEBA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb799b46-FRA
expires: Tue, 12 Sep 2023 09:00:31 GMT

GET
H2 200 webfontloader.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/litespeed-cache/assets/js/ 12 KB
5 KB 62ms
58ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/litespeed-cache/assets/js/webfontloader.min.js

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6f58202a14e2dcb4c672d6e9f0881ddc2b4e88225a97aadd940400a7377ee02d

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:28 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:44:24 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119699
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=AT%2Btek2d94GbbbNTkBaPJ8FjJUp5S%2BAIfr9ZnxVQYYM9880lroBC0v4e3INGJ7s5bMo1RPlTX3EeR0x0lmXaP%2FF0eAMaQhwdqTxGZ8Qe1SsE9EW72jYM4a3Rg1eLSismJPg6aQec9VaRjzuGeBgBLzUxeNz61iyTnr36%2BtLRs%2FKVyw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca05fb7b9b46-FRA
expires: Tue, 12 Sep 2023 09:00:42 GMT

GET
H2 200 optimize.js Show response
www.googleoptimize.com/ 124 KB
48 KB 93ms
20ms Script
application/javascript 2a00:1450:4001:82b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googleoptimize.com/optimize.js?id=OPT-TN6VR7M

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/scripts/7d0fa10a/cloudflare-static/rocket-loader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

378960341d22bd9b3e9c3843eff3ea319707448fbd9bbae7517f20509c33ca66

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 49029
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2

200

main.js Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/ Frame 219E
Redirect Chain

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js
https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

7 KB
4 KB

14ms
13ms

Script
application/javascript

2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

Requested by

Protocol

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8a13903882d971cebc8c1062aaf2158127dfc3f482f1fcb864451fe8cd803b18

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: accept-encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=GEcyWnVASvl0yl%2BrlldoyTQC3QGEkEHSkSaJziHkltkiUUhJS7RLMbSk6Y0InDB%2FFOELpibky0k%2BEP4M4wDXsXv73r53vRIswf4HXwXCS9%2FNeHxWGrpqS3KLkY3qLtTDx5KbtEYOo2L%2Fa8R%2FzY6dsdYEANRpJVZaJcMTdgUFNf%2Fypw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=UTF-8
cache-control: max-age=14400, public
cf-ray: 8028ca066c0d9b46-FRA

Redirect headers

date: Wed, 06 Sep 2023 18:31:28 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: accept-encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=lhC7gg7FAc3R4BeJEN%2FkkTdvAnFTIiR7MwHyu69%2BbBdkPgJyfkQw4JLWCyYUB5u5CxTdiWBntT6SYggSLJWvZ3LN48hGb%2FYtCPDijW2R%2FVMnFBYtkBXvp%2FofVe0YE7X4xlfVxevl7%2FaaKJ4Yr85RzUUNfvQc9MmXNhQgPlrvQ43WmA%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-allow-origin: *
location: /cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js
cache-control: max-age=300, public
cf-ray: 8028ca05fb7c9b46-FRA

GET
H2 200 linkid.js Show response
www.google-analytics.com/plugins/ua/ 2 KB
1 KB 12ms
11ms Script
text/javascript 2a00:1450:4001:831::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/plugins/ua/linkid.js

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:26:41 GMT
content-encoding: br
x-content-type-options: nosniff
age: 287
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 697
x-xss-protection: 0
last-modified: Fri, 30 Jun 2023 18:58:00 GMT
server: sffe
vary: Accept-Encoding
report-to: {"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type: text/javascript
cache-control: public, max-age=3600
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="static-on-bigtable"
expires: Wed, 06 Sep 2023 19:26:41 GMT

POST
H3 200 collect Show response
www.google-analytics.com/j/ 15 B
35 B 15ms
14ms XHR
text/plain 2a00:1450:4001:831::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/j/collect?v=1&_v=j101&aip=1&a=255749642&t=pageview&_s=1&dl=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&ul=en-us&de=UTF-8&dt=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aGBAgUAjCAAAACAAI~&jid=726640347&gjid=1148924212&cid=1717306311.1694025089&tid=UA-10556842-6&_gid=1817675551.1694025089&_slc=1&cd3=bavarian-nordic%20janssen-pharmaceuticals-inc%20oxford-vaccines-group&cd6=ebola-virus&cd9=cpeachey&cd10=news&cd11=20150715&z=490204896

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

0652f37cb87881481399eae1bd2e005378b6ba663c27efc285ade4832f428035

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 200 collect Show response
stats.g.doubleclick.net/j/ 4 B
364 B 64ms
22ms XHR
text/plain 2a00:1450:400c:c0c::9a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-10556842-6&cid=1717306311.1694025089&jid=726640347&gjid=1148924212&_gid=1817675551.1694025089&_u=aGBAgUAjCAAAAGAAI~&z=214660296

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:400c:c0c::9a Brussels, Belgium, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

aceb906b19be5a14a045dc9d5c9b04b948ef85f4aff28394e7453bea3c3d9422

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
strict-transport-security: max-age=10886400; includeSubDomains; preload
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 4
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 200 8028ca03c88b9b46 Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/jsd/r/ Frame 219E 0
499 B 39ms
39ms XHR
text/plain 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/jsd/r/8028ca03c88b9b46
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/json

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 8028ca076d539b46-FRA
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vnOuQ4B2YOQo1qw%2Fk3u31uKPmzXoyrlX1159xaaSvcbqpV5Yuhw%2Ff6%2Bl5pC6JAQsaenqHgPObH3TCOA8lY2raRu3AxfQGs9%2BaC3ux6TvKYlhvUR1WXLk5v1f2Iz7ZSWUkKKQo54%2FWghQJ9jYY5AzDWeCJ0LJXHEqAp285tDAqBsXYg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/plain; charset=UTF-8

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 242 KB
83 KB 56ms
33ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-H1P066ENQD&cx=c&_slc=1

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

196797bf8fe4e7183756b1400cdd9c06802f69d6d9c01942f8bfa570e7bd8c19

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 84814
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 ga-audiences
www.google.com/ads/ 42 B
296 B 50ms
49ms Image
image/gif 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-10556842-6&cid=1717306311.1694025089&jid=726640347&_u=aGBAgUAjCAAAAGAAI~&z=2137569903

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ga-audiences
www.google.gr/ads/ 42 B
408 B 76ms
53ms Image
image/gif 2a00:1450:4001:831::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.gr/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-10556842-6&cid=1717306311.1694025089&jid=726640347&_u=aGBAgUAjCAAAAGAAI~&z=2137569903

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 191 KB
68 KB 37ms
37ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-P89LTFL

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

e0243ca2778c12801255144cef22a1b95740c2bf343c0b65286fb36d1c8da029

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 69377
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 css
fonts.googleapis.com/ 8 KB
766 B 19ms
18ms Stylesheet
text/css 2a00:1450:4001:808::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-content/plugins/litespeed-cache/assets/js/webfontloader.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

daaebd8f5c4ada75f9a08b6bde0a25d3cb9bb4c87e4f78d4a242d3c94a373a0c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:31:29 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 wp-emoji-release.min.js Show response
www.europeanpharmaceuticalreview.com/wp-includes/js/ 18 KB
5 KB 30ms
30ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-includes/js/wp-emoji-release.min.js?ver=6.1.3

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5aad5fbd4238981a9ff5e2772ff1353dfe1a801fb49542fe157418c1438f7782

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 03 Aug 2022 11:32:34 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 120472
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=oU61omVD4jYHa8nYNe%2ByvsyTMMFiY4qGeoY1r1yeBN3Qj5wrSFpl1NWP%2Feo4Iwwu4qoSBSsiIl5Dw8c7kGEKIAFb%2FZidARi7N0cTTZ02mUgULHRWpTzqmFwbFK8bIhwDD0qMEcoWh1Ib4CXyxK6lBSCnJbsm3P0E7HlkzM5r8ZX5Qw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca07bdb69b46-FRA
expires: Tue, 12 Sep 2023 09:00:42 GMT

GET
H2 200 NaPDcZTIAOhVxoMyOr9n_E7ffGjEGItzYw.woff2
fonts.gstatic.com/s/titilliumweb/v17/ 12 KB
12 KB 73ms
31ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/titilliumweb/v17/NaPDcZTIAOhVxoMyOr9n_E7ffGjEGItzYw.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

d14d732f8caf915919ff661157edc3456a85f408b7a3c5ee1e21357e7df07e1a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Fri, 01 Sep 2023 16:04:43 GMT
x-content-type-options: nosniff
age: 440806
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 12384
x-xss-protection: 0
last-modified: Thu, 24 Aug 2023 21:03:57 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 31 Aug 2024 16:04:43 GMT

GET
H2 200 NaPecZTIAOhVxoMyOr9n_E7fdMPmDQ.woff2
fonts.gstatic.com/s/titilliumweb/v17/ 12 KB
12 KB 73ms
32ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/titilliumweb/v17/NaPecZTIAOhVxoMyOr9n_E7fdMPmDQ.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

557f6d0883db85be712c3a77baa38875ddf99ecbdfd6fec98e5c0b1f7a0e1532

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Fri, 01 Sep 2023 15:37:55 GMT
x-content-type-options: nosniff
age: 442414
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 12372
x-xss-protection: 0
last-modified: Thu, 24 Aug 2023 20:30:13 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 31 Aug 2024 15:37:55 GMT

GET
H2 200 NaPDcZTIAOhVxoMyOr9n_E7ffBzCGItzYw.woff2
fonts.gstatic.com/s/titilliumweb/v17/ 12 KB
12 KB 64ms
23ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/titilliumweb/v17/NaPDcZTIAOhVxoMyOr9n_E7ffBzCGItzYw.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

dd870101ad4e95d687a2eb734707b0dd7c20808f76d7be77a71a5d13cf99401c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Fri, 01 Sep 2023 15:20:48 GMT
x-content-type-options: nosniff
age: 443441
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 12136
x-xss-protection: 0
last-modified: Thu, 24 Aug 2023 21:07:01 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 31 Aug 2024 15:20:48 GMT

GET
H2 200 7Auwp_0qiz-afTLGLQ.woff2
fonts.gstatic.com/s/muli/v28/ 30 KB
31 KB 57ms
16ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/muli/v28/7Auwp_0qiz-afTLGLQ.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

2a04078f9550381b5148170ceaf5b378a1b31ed8274c6d0094aeba6f599462cc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 05:12:59 GMT
x-content-type-options: nosniff
age: 393510
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31196
x-xss-protection: 0
last-modified: Mon, 11 Jul 2022 20:43:05 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 05:12:59 GMT

GET
H2 200 7Au-p_0qiz-afTf2LwLT.woff2
fonts.gstatic.com/s/muli/v28/ 31 KB
31 KB 67ms
26ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/muli/v28/7Au-p_0qiz-afTf2LwLT.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

542aa3a659dae23a91406e12842f7c1554e955238427f8374c6a1e17bfdb1940

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 02:32:30 GMT
x-content-type-options: nosniff
age: 403139
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 32108
x-xss-protection: 0
last-modified: Mon, 11 Jul 2022 21:01:21 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 02:32:30 GMT

GET
H2 200 7Auwp_0qiz-afTLGLQ.woff2
fonts.gstatic.com/s/muli/v28/ 30 KB
31 KB 73ms
33ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/muli/v28/7Auwp_0qiz-afTLGLQ.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

2a04078f9550381b5148170ceaf5b378a1b31ed8274c6d0094aeba6f599462cc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 05:12:59 GMT
x-content-type-options: nosniff
age: 393510
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31196
x-xss-protection: 0
last-modified: Mon, 11 Jul 2022 20:43:05 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 05:12:59 GMT

GET
H2 200 7Au-p_0qiz-afTf2LwLT.woff2
fonts.gstatic.com/s/muli/v28/ 31 KB
31 KB 80ms
40ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/muli/v28/7Au-p_0qiz-afTf2LwLT.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

542aa3a659dae23a91406e12842f7c1554e955238427f8374c6a1e17bfdb1940

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 02:32:30 GMT
x-content-type-options: nosniff
age: 403139
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 32108
x-xss-protection: 0
last-modified: Mon, 11 Jul 2022 21:01:21 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 02:32:30 GMT

GET
H2 200 7Auwp_0qiz-afTLGLQ.woff2
fonts.gstatic.com/s/muli/v28/ 30 KB
31 KB 76ms
36ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/muli/v28/7Auwp_0qiz-afTLGLQ.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600%7CMuli:300,300i,400,400i,600,i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

2a04078f9550381b5148170ceaf5b378a1b31ed8274c6d0094aeba6f599462cc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 05:12:59 GMT
x-content-type-options: nosniff
age: 393510
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31196
x-xss-protection: 0
last-modified: Mon, 11 Jul 2022 20:43:05 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 05:12:59 GMT

POST
H2 204 collect
region1.analytics.google.com/g/ 0
269 B 43ms
15ms Ping
text/plain 2001:4860:4802:32::36
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://region1.analytics.google.com/g/collect?v=2&tid=G-H1P066ENQD&gtm=45je38u0&_p=255749642&_gaz=1&ul=en-us&sr=1600x1200&cid=1717306311.1694025089&ir=1&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_eu=EBAI&_s=1&dl=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&dt=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&sid=1694025089&sct=1&seg=0&en=page_view&_fv=1&_ss=1&_ee=1&ep.ua_dimension_3=bavarian-nordic%20janssen-pharmaceuticals-inc%20oxford-vaccines-group&ep.ua_dimension_6=ebola-virus&ep.ua_dimension_9=cpeachey&ep.ua_dimension_10=news&ep.ua_dimension_11=20150715
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-H1P066ENQD&cx=c&_slc=1
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 204 collect
stats.g.doubleclick.net/g/ 0
56 B 25ms
24ms Ping
text/plain 2a00:1450:400c:c0c::9a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://stats.g.doubleclick.net/g/collect?v=2&tid=G-H1P066ENQD&cid=1717306311.1694025089&gtm=45je38u0&aip=1
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-H1P066ENQD&cx=c&_slc=1
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:400c:c0c::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ga-audiences
www.google.gr/ads/ 42 B
107 B 53ms
53ms Image
image/gif 2a00:1450:4001:831::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.gr/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-H1P066ENQD&cid=1717306311.1694025089&gtm=45je38u0&aip=1&z=47367583

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 233 KB
81 KB 22ms
22ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-Y65RLNHTF0&l=dataLayer&cx=c

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-P89LTFL

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

df064da943ce28c544cd3da59dbffc0216fa5c9030f4bbd1a44a5731880424fe

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 82967
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 tracker.js Show response
t.wowanalytics.co.uk/Scripts/ 13 KB
7 KB 80ms
14ms Script
text/javascript 37.221.223.17
SPOTLER Spotler N...

General

Check archive.org

Show headers Download Go to

Full URL: https://t.wowanalytics.co.uk/Scripts/tracker.js
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 37.221.223.17 , United Kingdom, ASN51514 (SPOTLER Spotler Network, NL),
Reverse DNS: mail17.tgml2.co.uk
Software: Caddy /
Resource Hash: 8a539ece7f6e7477bc1ddf72d1a3f977fee067352471fadc0cd31705f9fd4739

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-backend: web41
age: 10683
x-cache: HIT 26674 spuk-var01
cad-forwarded-for: 81.95.5.42
content-length: 6739
x-client-ip: 10.118.6.11
server: Caddy
etag: -810932213
vary: Accept-Encoding
content-type: text/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public
access-control-allow-credentials: true
x-client-id: 10.118.6.11
t-caddyhead: 101
accept-ranges: bytes
expires: Wed, 06 Sep 2023 17:31:03 GMT

GET
H3 200 js Show response
www.googletagmanager.com/gtag/ 194 KB
70 KB 24ms
24ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-964653157&l=dataLayer&cx=c

Requested by

Host: www.googleoptimize.com
URL: https://www.googleoptimize.com/optimize.js?id=OPT-TN6VR7M

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

77aef0593cba55488a7ceddae4d3298189468f289a286724fd241e3d7756008f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 71827
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 insight.min.js Show response
snap.licdn.com/li.lms-analytics/ 12 KB
4 KB 72ms
8ms Script
application/x-javascript 2a02:26f0:480:f::213:7ec6
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:480:f::213:7ec6 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

28a26321734fb5f8c8fe42b5503f162fdf1469bf97e2d9c503a83cc2b3c534cd

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

x-edgeconnect-origin-mex-latency: 615
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 05 Sep 2023 13:41:52 GMT
x-cdn: AKAM
x-edgeconnect-midmile-rtt: 0
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: application/x-javascript;charset=utf-8
cache-control: max-age=60381
accept-ranges: bytes
content-length: 3822

GET
H2 200 MML_HTMLorMML.js Show response
cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/config/ 154 KB
38 KB 36ms
35ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/config/MML_HTMLorMML.js?V=2.7.0

Requested by

Host: cdnjs.cloudflare.com
URL: https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=MML_HTMLorMML

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

131109318044868d0e193e1ce55d355b0f75ee31e84d89630017c4f92f85d13d

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 14230932
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 38800
last-modified: Mon, 04 May 2020 16:13:06 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb03f12-2669f"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=WMqLtrCVCjFn6B5x3qJx%2Fn6ZyDv6kNEk5dCrn6lILl4lnFJcF6GftdrPRZvb9yVD0%2BA4QBItDD3oy1TLSpqwY%2BSu%2BUODlDuLigNX%2BH1pNDxGe8fma3xpEK9eoFDkxU1oGSYcYckEy%2BCqCE7D9IFg%2FcAb"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 8028ca08bc7cbbf7-FRA
expires: Mon, 26 Aug 2024 18:31:29 GMT

GET
H2 200 / Show response
googleads.g.doubleclick.net/pagead/viewthroughconversion/964653157/ 3 KB
2 KB 78ms
52ms Script
text/javascript 2a00:1450:4001:811::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/964653157/?random=1694025089403&cv=11&fst=1694025089403&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hn=www.googleadservices.com&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&auid=545148852.1694025089&uamb=0&uaw=0&data=event%3Dgtag.config&rfmt=3&fmt=4

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-964653157

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

f6aa246ff197457e3ea619a18ea12ef8160e787d0f22c3a350e061bb5f3fab4a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
server: cafe
content-type: text/javascript; charset=UTF-8
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 1455
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 / Show response
googleads.g.doubleclick.net/pagead/viewthroughconversion/964653157/ 3 KB
2 KB 78ms
55ms Script
text/javascript 2a00:1450:4001:811::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/964653157/?random=1694025089413&cv=11&fst=1694025089413&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&hn=www.googleadservices.com&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&value=replace%20with%20value&auid=545148852.1694025089&uamb=0&uaw=0&data=event%3Dpage_view%3Bgoogle_business_vertical%3Dcustom%3Bid%3Dreplace%20with%20value%3Blocation_id%3Dreplace%20with%20value&rfmt=3&fmt=4

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-964653157

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

b36b3e9fe37de4ed754769f24ea6b1e57f2fd245a55e0a2e7d815cf7057b922e

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
server: cafe
content-type: text/javascript; charset=UTF-8
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 1504
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 204 collect
region1.analytics.google.com/g/ 0
45 B 17ms
16ms Ping
text/plain 2001:4860:4802:32::36
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://region1.analytics.google.com/g/collect?v=2&tid=G-Y65RLNHTF0&gtm=45je38u0&_p=255749642&_gaz=1&cid=1717306311.1694025089&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_s=1&sid=1694025089&sct=1&seg=0&dl=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&dt=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&en=page_view&_fv=1&_ss=1
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-Y65RLNHTF0&l=dataLayer&cx=c
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H3 204 collect
stats.g.doubleclick.net/g/ 0
17 B 19ms
19ms Ping
text/plain 2a00:1450:400c:c0c::9a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://stats.g.doubleclick.net/g/collect?v=2&tid=G-Y65RLNHTF0&cid=1717306311.1694025089&gtm=45je38u0&aip=1
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-Y65RLNHTF0&l=dataLayer&cx=c
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 2a00:1450:400c:c0c::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 ga-audiences
www.google.gr/ads/ 42 B
63 B 65ms
65ms Image
image/gif 2a00:1450:4001:831::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.gr/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-Y65RLNHTF0&cid=1717306311.1694025089&gtm=45je38u0&aip=1&z=2053926289

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 200 admin-ajax.php Show response
www.europeanpharmaceuticalreview.com/wp-admin/ 119 B
815 B 688ms
688ms XHR
text/html 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-admin/admin-ajax.php

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.1

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

509e8b786e3475eaaa81f8103e1017372c00b21dd992373faf5ca6dd7a6f358b

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN,SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
X-Requested-With: XMLHttpRequest
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

cf-edge-cache: cache,platform=wordpress
date: Wed, 06 Sep 2023 18:31:30 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
x-litespeed-cache-control: no-cache
referrer-policy: strict-origin-when-cross-origin
server: cloudflare
x-frame-options: SAMEORIGIN,SAMEORIGIN
vary: Accept-Encoding
content-type: text/html; charset=UTF-8
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=hGp6PByUPsCF9GqEs5fPtRydgOtncEbYmRfX9ibxGnQ5qgv3T1J8DVcSvDDOWNbkwv09jyN5RSpB0ZNW8hJiD5BScHsTNUwqooZ%2F%2B9VMcXGWgcDoduTBxGoGuKU3c3HD8Iuw6%2F4rQI1itltjgHjA1aHeAN5nz%2FY7B9PFpmN6lTLGLA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: no-cache, must-revalidate, max-age=0
access-control-allow-credentials: true
x-turbo-charged-by: LiteSpeed
x-robots-tag: noindex
cf-ray: 8028ca0918279b46-FRA
expires: Wed, 11 Jan 1984 05:00:00 GMT

POST
H2 200 admin-ajax.php Show response
www.europeanpharmaceuticalreview.com/wp-admin/ 119 B
411 B 705ms
705ms XHR
text/html 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-admin/admin-ajax.php

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.1

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

509e8b786e3475eaaa81f8103e1017372c00b21dd992373faf5ca6dd7a6f358b

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN,SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
X-Requested-With: XMLHttpRequest
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

cf-edge-cache: cache,platform=wordpress
date: Wed, 06 Sep 2023 18:31:30 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
x-litespeed-cache-control: no-cache
referrer-policy: strict-origin-when-cross-origin
server: cloudflare
x-frame-options: SAMEORIGIN,SAMEORIGIN
vary: Accept-Encoding
content-type: text/html; charset=UTF-8
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=77KgMsDrhtpd7PTho8k%2Bwu2QSyKxjh6w7ATTZCLRVvuflVGVz43lvt3g8ufV0QphiMpDcdCB60w0sWKFrQ%2BzLHlo1cUjQ86bKp%2FMimDZaEZnL0Fz8Q8p7GANEORhUglcuwQUWDCNRT3RNaiCP%2Bw0lQ6YT5scpP3tlXFpD9nRnAUe2w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: no-cache, must-revalidate, max-age=0
access-control-allow-credentials: true
x-turbo-charged-by: LiteSpeed
x-robots-tag: noindex
cf-ray: 8028ca09182b9b46-FRA
expires: Wed, 11 Jan 1984 05:00:00 GMT

GET
H/1.1 200
OK Capture.aspx Show response
secure.leadforensics.com/Track/ 0
160 B 37ms
37ms Script
text/plain 51.140.49.131
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to

Full URL: https://secure.leadforensics.com/Track/Capture.aspx?retType=js&trk_uid=&trk_user=223774&trk_sw=1600&trk_sh=1200&trk_ref=&trk_tit=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&trk_loc=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&trk_agn=Netscape&trk_agv=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F116.0.5845.179%20Safari%2F537.36.lfcd24.lflng&trk_dom=www.europeanpharmaceuticalreview.com&trk_cookie=NA&trk_culid=01H9NW70E6MQF4S083BZ65N3XH
Requested by: Host: secure.leadforensics.com
URL: https://secure.leadforensics.com/js/223774.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 51.140.49.131 London, United Kingdom, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: Kestrel /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

Date: Wed, 06 Sep 2023 18:31:29 GMT
Server: Kestrel
Content-Length: 0
Request-Context: appId=cid-v1:abe8a76f-f1a2-4b2e-9017-0ea36ffb5c20

GET
H2 204 any Show response
idx.liadm.com/idex/unknown/ 0
209 B 299ms
95ms XHR
text/plain 52.204.63.111
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://idx.liadm.com/idex/unknown/any?gdpr=1&n3pc=1

Requested by

Host: secure.leadforensics.com
URL: https://secure.leadforensics.com/js/223774.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.204.63.111 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-52-204-63-111.compute-1.amazonaws.com

Software

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
date: Wed, 06 Sep 2023 18:31:29 GMT
strict-transport-security: max-age=31536000; includeSubDomains
access-control-allow-credentials: true
trace-id: fe5a69917616afb9
vary: Origin
request-time: 0

GET
H2 200 insight.old.min.js Show response
snap.licdn.com/li.lms-analytics/ 13 KB
5 KB 15ms
14ms Script
application/x-javascript 2a02:26f0:480:f::213:7ec6
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.old.min.js

Requested by

Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:480:f::213:7ec6 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

fa53fcd8da139d256c0ca83b69cb37473ca627b6052368ed3327c80d9fb61e25

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 28 Aug 2023 12:14:15 GMT
x-cdn: AKAM
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: application/x-javascript;charset=utf-8
cache-control: max-age=64621
accept-ranges: bytes
content-length: 4862

GET
H2 200 mml3.js Show response
cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/extensions/MathML/ 24 KB
4 KB 22ms
21ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/extensions/MathML/mml3.js?V=2.7.0

Requested by

Host: cdnjs.cloudflare.com
URL: https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=MML_HTMLorMML

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e8e3b7e10ae5885f316f79ea863d10b8f7400484c871da9fbf78fb2caba9a15c

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 11053413
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 3958
last-modified: Mon, 04 May 2020 16:13:06 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb03f12-606a"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=csoxFnfoP3a5BeeeXAXysswii07NNMxiBoNOZpZIC06SxjacUe%2BoyqK0rwwDaec00eAiMXurg5%2FZOYv4i8ZSZHpUpOPgZyKT%2B%2B86RCr2P%2Ff5MTyfiY9pm0MoY8BGtAhJL3uZS4CGd4%2FMBF9hNs3u2rqF"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 8028ca095d7fbbf7-FRA
expires: Mon, 26 Aug 2024 18:31:29 GMT

GET
H2 200 content-mathml.js Show response
cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/extensions/MathML/ 30 KB
7 KB 22ms
21ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/extensions/MathML/content-mathml.js?V=2.7.0

Requested by

Host: cdnjs.cloudflare.com
URL: https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=MML_HTMLorMML

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

fe65077a468cd59053551033596f3ca0b7380271b89f00a8f58a66ce7162a9cc

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 6525935
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 6514
last-modified: Mon, 04 May 2020 16:13:06 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb03f12-7685"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=0JgHQLivKEovwqaWYkxD%2FvllGpJBtzlMNhP0L94WUov29ARzx49PnpG2mudmBNZ95rFQhg5yBlXQF8XzkN8Uw9ALMQ9jv2kj%2BWRNDYmnKZ2CAHvTxPBe2FA2m1w21t%2BzYLxAHRmZRO0h%2BtxcssJ9QCv2"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 8028ca095d81bbf7-FRA
expires: Mon, 26 Aug 2024 18:31:29 GMT

GET
H2 200 / Show response
t.gatorleads.co.uk/Tracking/TrackUrlGet/ 190 B
495 B 132ms
64ms Script
application/x-javascript 37.221.223.30
SPOTLER Spotler N...

General

Check archive.org

Show headers Download Go to

Full URL: https://t.gatorleads.co.uk/Tracking/TrackUrlGet/?clientid=96c22c17-e6e3-46d8-936e-89c284cdd9d2&cust1=&cust2=&cust3=news&pageUrl=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&pageTitle=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&referrerUrl=&trackingdata=&sessionId=&pageType=Page&schedule=&utmvalues=&callback=window.wowCallback0
Requested by: Host: t.wowanalytics.co.uk
URL: https://t.wowanalytics.co.uk/Scripts/tracker.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 37.221.223.30 , United Kingdom, ASN51514 (SPOTLER Spotler Network, NL),
Reverse DNS: mail30.tgml2.co.uk
Software: Caddy /
Resource Hash: 435d55dcce5dd9e7f92ba076d669ff729228204358fa196158c3c2b2a983b727

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-backend: web43
age: 0
x-cache: MISS spuk-var01
cad-forwarded-for: 81.95.5.42
content-length: 245
x-client-ip: 10.118.6.11
server: Caddy
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
cache-control: private
access-control-allow-credentials: true
x-client-id: 10.118.6.11
t-caddyhead: 101
accept-ranges: bytes

GET
H2 200 accessibility-menu.js Show response
cdn.mathjax.org/mathjax/contrib/a11y/ 3 KB
2 KB 67ms
14ms Script
application/javascript 2606:4700:20::681a:cdc
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.mathjax.org/mathjax/contrib/a11y/accessibility-menu.js?V=2.7.0
Requested by: Host: cdnjs.cloudflare.com
URL: https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=MML_HTMLorMML
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::681a:cdc , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4c78cb8dfcc1a971c55b0bc87cdbf4bf0a4417e5c9726f1a6952ca3932acb704

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 1688524
x-guploader-uploadid: ADPycdsf9dFllq51uTAnl2Jj3XeRpDCwgfS7hYFUBBE6fpm0jvCp4WZlXs1RtoQaC4RLTyzVQHWH6HvJ8aNMYqB0EMAFqQ
x-goog-storage-class: STANDARD
x-goog-metageneration: 1
x-goog-stored-content-encoding: identity
last-modified: Fri, 14 Oct 2016 07:05:19 GMT
server: cloudflare
etag: W/"3f0679e15e23a3dcbcd074ceb33d3e8c"
vary: Accept-Encoding
x-goog-hash: crc32c=VbO4VA==, md5=PwZ54V4jo9y80HTOsz0+jA==
x-goog-generation: 1476428719133000
content-type: application/javascript
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: public, max-age=16070400
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=R1de6ZK9hgy%2FmSpdOFkU5oryy1%2Fp1Bc7EkjaN0LgvMIRYWTjuZrlXgjrzqE1%2Foza1QxJ4ddKHrja5W%2BMwwQYIKvp8%2BivCvZLVodumQEgLjg1P0pVysUyNqg2IuUj%2FdWdXZbYffpL%2Bevo45ForQ%3D%3D"}],"group":"cf-nel","max_age":604800}
x-goog-stored-content-length: 2893
cf-ray: 8028ca09b94c9208-FRA
expires: Fri, 18 Aug 2023 06:29:25 GMT

GET
H3 200 /
www.google.com/pagead/1p-user-list/964653157/ 42 B
64 B 26ms
25ms Image
image/gif 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/pagead/1p-user-list/964653157/?random=1694025089403&cv=11&fst=1694023200000&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&data=event%3Dgtag.config&fmt=3&is_vtc=1&random=3808577616&rmt_tld=0&ipr=y

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-security-policy: script-src 'none'; object-src 'none'
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 /
www.google.gr/pagead/1p-user-list/964653157/ 42 B
64 B 25ms
25ms Image
image/gif 2a00:1450:4001:831::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.gr/pagead/1p-user-list/964653157/?random=1694025089403&cv=11&fst=1694023200000&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&data=event%3Dgtag.config&fmt=3&is_vtc=1&random=3808577616&rmt_tld=1&ipr=y

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-security-policy: script-src 'none'; object-src 'none'
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/304042/domain/europeanpharmaceuticalreview.com/ 36 B
373 B 79ms
9ms XHR
application/json 2600:9000:20eb:8000:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/304042/domain/europeanpharmaceuticalreview.com/token
Requested by: Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.old.min.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:20eb:8000:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.europeanpharmaceuticalreview.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:24:48 GMT
content-encoding: gzip
via: 1.1 0b9e85cfe8fe19b385db56d32b4ce802.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA2-C1
age: 401
vary: accept-encoding
x-cache: Hit from cloudfront
content-type: application/json
access-control-allow-origin: *
cache-control: public, max-age=3600
x-amz-cf-id: 88K3A-a7TiULnnF-2lFmL0svq5ElhSd3ZpfdOA36AaZi5kQw2xOPPQ==

GET
H2

200

collect
px4.ads.linkedin.com/
Redirect Chain

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-...
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D304042%26time%3D1694025089509%26url%3Dhttps%253A%252F%252Fwww.europeanpharmaceuti...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-...
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of...

0
266 B

204ms
154ms

Image
application/javascript

13.107.42.14
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&cookiesTest=true&liSync=true&e_ipv6=AQKbDK-Pf5IYNAAAAYprw4TfQDzuJh5_zJvUcrtwla7y4eTX09AyvzylnDF5JWfw
Protocol: H2
Server: 13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
x-li-pop: afd-prod-ltx1-x
x-msedge-ref: Ref A: 998303F3351B43378541F9F50F59608E Ref B: DUS30EDGE0905 Ref C: 2023-09-06T18:31:30Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
content-type: application/javascript
x-li-fabric: prod-ltx1
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYEtPPC26swmu/IS8/d+w==

Redirect headers

date: Wed, 06 Sep 2023 18:31:30 GMT
x-li-pop: afd-prod-ltx1-x
x-msedge-ref: Ref A: 32949BA5E2D14988BC67B01F7742D2C1 Ref B: FRAEDGE1714 Ref C: 2023-09-06T18:31:30Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
x-li-fabric: prod-ltx1
location: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=304042&time=1694025089509&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&cookiesTest=true&liSync=true&e_ipv6=AQKbDK-Pf5IYNAAAAYprw4TfQDzuJh5_zJvUcrtwla7y4eTX09AyvzylnDF5JWfw
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYEtPO+73ihPxOhelf6sA==

GET
H2 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/ 454 KB
183 KB 56ms
7ms Script
text/javascript 2a00:1450:4001:806::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/recaptcha__de.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api.js?render=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&ver=3.0

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

587fc1c1e943e8763bd2e2ff0be4a0e5efc61181b1a4834c99aac812c5c126a0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
Origin: https://www.europeanpharmaceuticalreview.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:10:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 1235
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 186637
x-xss-protection: 0
last-modified: Mon, 21 Aug 2023 02:02:34 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 05 Sep 2024 18:10:54 GMT

GET
H2 200 pinterest-pro.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/ 9 KB
3 KB 33ms
32ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/pinterest-pro.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

599fc36cdbfa2e704431b32f80c0da4d9f1207860923856f9aaf94ec34485b1e

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119700
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=PR%2BJKMAVoZF8MigXPqkp67QxJrFk9V6HDhVrGlsYDMry0O3pIfxC9ilJjqiLOmo17XMQ3GZPLk5TvERD1JLoDbHhet5uzdcz%2Fk8N4dpPmaFTBC8%2FOtCxuJkAsfspz%2Btzp4oVFXMM2nDoXDfNOKHNOyk5zJfSVDy2177sLsoo0HMA6A%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca09b8d29b46-FRA
expires: Tue, 12 Sep 2023 09:00:45 GMT

GET
H2 200 subscribe-forms.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/ 10 KB
3 KB 32ms
31ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/modules/subscribe-forms.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c4dfcf0a7f1361d7343478a34b55ac4f8e93eeb3946e207910c1d5c6f40399bc

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119700
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1oHdJXrCckQgbiUIyiXwtiVXWIl%2FfcDZvUHjCUE1MArGUyu3yvxY%2FfzxPYasdv8NdGEB2pf3OhN0K6U3OsUd8b4ltOYJMaGhF0gwbCbkbwvehttHCkcCDkPeP2OBkPEwoBKQJC73gUTGqWWRg3XqfUosbluMgfRzFgvFi%2Fl644TA7Q%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca09b8d39b46-FRA
expires: Tue, 12 Sep 2023 09:00:45 GMT

GET
H2 200 essb-core.min.js Show response
www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/js/ 36 KB
10 KB 35ms
34ms Script
application/javascript 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/plugins/easy-social-share-buttons3/assets/js/essb-core.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

aecd7eb2b6e701d96fa190da001f4d25401b8d8c9fba92e3638cda852b27d2c2

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Wed, 22 Mar 2023 19:40:17 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
age: 119700
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: application/javascript
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=iW7VJbuDYHNeSOmQPNFvHe%2FU%2BD7U2cB7uFRMduDMuB4uzePSL3xZhMg3mfh4zEfSl%2B9H9LnIiEyi8kNje12%2F6y7mYrhTjZ4vlrFYIaWPQWpI7n0HZvgFDdlVUZveDnLY5qQhTQTQShRpe6%2FpiTdBGx%2BeNnHlhJ5hoiJ9PkeOQ8i9gQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca09b8d59b46-FRA
expires: Tue, 12 Sep 2023 09:00:45 GMT

GET
H2

200

main.js Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/ Frame 219E
Redirect Chain

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js
https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

7 KB
4 KB

18ms
17ms

Script
application/javascript

2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js

Protocol

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

612d588108be3cacc40377b989014ca394cda96a6a1fed922804a2bf58e9c6d5

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
x-content-type-options: nosniff
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: accept-encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=15cah3Uvt6dKGwaPnpRO2D7Vz%2By8wrsVuXWIAE4vaAjvymdNT1eeoCKFUm2zRfVoH7QP71WSqGc8kXQP2UUJTYa9NYowfFG2dA9gnMpq6TewjFvEbj3rAKgYwIiFibAr0Zd1Zm0y2HRX7Bf3vJ%2FVjXVE%2BjAjwsDW6DuABGv9CcRW4g%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=UTF-8
cache-control: max-age=14400, public
cf-ray: 8028ca0a29889b46-FRA

Redirect headers

date: Wed, 06 Sep 2023 18:31:29 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
vary: accept-encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xGpqUu67Qmbme6xO3xeegtHhUfz1n7%2B7tyCC10%2BALOiqjpuFJRebQAd9d688VgXLG7y8eATcxJKn62nFjF2qO%2B3nhuMlPs7rPQscgbvHTO2Y%2Fow4KLqjTnOBrQdrFqCOHYY5k5nwZyYl4r0SWsOJX%2F7kmG0NSTqnGAxLBLazyQcgDQ%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-allow-origin: *
location: /cdn-cgi/challenge-platform/h/g/scripts/jsd/3e377faf/main.js
cache-control: max-age=300, public
cf-ray: 8028ca09b8da9b46-FRA

GET
H3 200 js Show response
www.googletagmanager.com/gtag/ 180 KB
65 KB 26ms
25ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=UA-10556842-6&l=dataLayer&cx=c

Requested by

Host: www.googleoptimize.com
URL: https://www.googleoptimize.com/optimize.js?id=OPT-TN6VR7M

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

16a58c953e842b2c6d7e9df0be63f988c6d27e026316a1fd00e6ce1a6d861e96

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 66623
x-xss-protection: 0
last-modified: Wed, 06 Sep 2023 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Wed, 06 Sep 2023 18:31:29 GMT

GET
H2 200 app.js Show response
servedbyadbutler.com/ 67 KB
13 KB 61ms
12ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://servedbyadbutler.com/app.js
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 7d9b7ee9ae860b2f27e08578dacc166269ab838417994fb62c568ff40245b5a3

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
last-modified: Fri, 17 Mar 2023 20:55:19 GMT
server: nginx
etag: W/"6414d3b7-10c8e"
vary: Accept-Encoding
content-type: application/javascript
cache-control: max-age=1800
expires: Wed, 06 Sep 2023 19:01:29 GMT

GET
H2 200 EPR-BYG-Banner.png
www.europeanpharmaceuticalreview.com/wp-content/uploads/ 90 KB
91 KB 32ms
27ms Image
image/webp 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPR-BYG-Banner.png

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

29a09388a9bacf4e7217bdac10fcd407c24096c882bb3eeeeab54d0e5fc78900

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 118886
cf-polished: origFmt=png, origSize=127297
content-disposition: inline; filename="EPR-BYG-Banner.webp"
content-length: 92306
cf-bgj: imgq:100,h2pri
last-modified: Wed, 02 Oct 2019 22:02:48 GMT
server: cloudflare
vary: Accept
x-frame-options: SAMEORIGIN
content-type: image/webp
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=L6V6%2FS%2B6XqxMJyBm8Tuj2E98dtXNPVsbyPg1MkK57BvY%2FfQ1lIx7Uy5yZY8zn6%2FFPzzaG8149Fc3mqCQZOYphtaGUug0jNchPPnLlM9h5ww%2FxPtxbCnpQ0cK%2Bd%2FhwauOc6UnkXSeAxpswJux%2B%2FgiZXryhFbQ%2FQz%2FU%2FhbFv%2BkBnqIiA%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca09d9109b46-FRA
expires: Tue, 12 Sep 2023 09:01:05 GMT

GET
H2 200 OneSignalPageSDKES6.js Show response
cdn.onesignal.com/sdks/ 284 KB
68 KB 27ms
25ms Script
application/javascript 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151604

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalSDK.js?ver=6.1.3

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

425197a561a2dc98259d7e284f708115b672f426a8adc0955f6f42fbaa61d7ae

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 1998
etag: W/"7f9669464fe15e6a516c0eb693b26dbb"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=259200
cf-ray: 8028ca09eeff5c98-FRA
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Sat, 09 Sep 2023 18:31:29 GMT

POST
H2 204 / Show response
www.europeanpharmaceuticalreview.com/ 0
315 B 544ms
544ms XHR
text/html 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/

Requested by

Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.1

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
X-Requested-With: XMLHttpRequest
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

cf-edge-cache: cache,platform=wordpress
date: Wed, 06 Sep 2023 18:31:30 GMT
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=8d87drTMFvtilORFfZ%2FuojK1o%2BtGdzt1nm1CvR7hE3Ua4sHL0BGZ42Yp5M1a3O87Kj13st7P6Ad%2BsnJo9Q6QQYoeq0mMFjoF%2BB6v4fSEqhNgzo2Io9DOGmInysjXxr0SpWUg5aZiN76ExOqFJkZVqYEmMFeW78isbmz0Lry3dqP%2FJQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/html; charset=UTF-8
x-litespeed-cache-control: no-cache
cache-control: max-age=15, s-maxage=0
x-turbo-charged-by: LiteSpeed
cf-ray: 8028ca0a19829b46-FRA

POST
H2 204 rum Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/ 0
174 B 17ms
17ms XHR
text/plain 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.europeanpharmaceuticalreview.com/cdn-cgi/rum?

Requested by

Host: static.cloudflareinsights.com
URL: https://static.cloudflareinsights.com/beacon.min.js/v8b253dfea2ab4077af8c6f58422dfbfd1689876627854

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
content-type: application/json

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
x-content-type-options: nosniff
server: cloudflare
vary: Origin
access-control-max-age: 86400
access-control-allow-methods: POST,OPTIONS
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
x-frame-options: DENY
access-control-allow-credentials: true
cf-ray: 8028ca0a39a49b46-FRA

GET
H2 200 epr-logo-large2.png
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/ 2 KB
3 KB 23ms
22ms Image
image/webp 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/epr-logo-large2.png

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2ee9b48ac5728cc661fe785e8b01598239eb16bb62f9fe1f759a36568826fbdc

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 118885
cf-polished: origFmt=png, origSize=5893
content-disposition: inline; filename="epr-logo-large2.webp"
content-length: 2318
cf-bgj: imgq:100,h2pri
last-modified: Fri, 02 Aug 2019 13:03:25 GMT
server: cloudflare
vary: Accept
x-frame-options: SAMEORIGIN
content-type: image/webp
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=W%2Bgmn9kNGlPhvaEFvLJcEA7HTKmfvbEtsyjFBGQIHcPOBHBy8XXKvQI5oO7vebBotKQLeLdMrFMUAMFSF%2BbF%2F%2FDK6SX%2BJUpWbwsvfIygNX0cSa8ekye94HaznFk6aYHMpRV19kqfhEEHldfOUGNCSImgwbk96L6co%2BOOzEhSsjDFpw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca0a59d09b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 ajax-loader.gif
www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/ 7 KB
8 KB 22ms
21ms Image
image/gif 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/themes/epr19/images/ajax-loader.gif

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

76d53e1090957412624c5923a30381ec8d815307bca6c3d88050047ce715da1b

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 118885
cf-polished: status=not_needed
content-length: 7299
cf-bgj: imgq:100,h2pri
last-modified: Fri, 02 Aug 2019 13:03:22 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Ef0VNIE9wVlCrexst%2FFMUj2ensKjfe6XQ56ZYyzBriV0pG52d7tgcBkwTTYEuIVg0aV81eLrTpa2z%2BPKYv4Y%2BIVHTqcgB4pXCPxnwI1DcYSYc49%2Fm6yVgmBY4xbbibcV07eM4CD1wMlDHp4C2ZJ4a9JGWvF5jeNIQcMnZmd%2F0JsmqQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca0a59d19b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 ebola-MVA-BN-Filo.jpg
www.europeanpharmaceuticalreview.com/wp-content/uploads/ 22 KB
23 KB 46ms
46ms Image
image/jpeg 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/ebola-MVA-BN-Filo.jpg

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

bfa4aa7cbd4c5dda6856193395db1b900cc1231ff7c73e2b14a6dac2c84fad6e

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-polished: origSize=22645
content-length: 22595
cf-bgj: imgq:100,h2pri
last-modified: Sat, 30 Apr 2016 18:45:48 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=J8p2jIy18eiNjRlQry9%2BDzSip0gV1JZzw9IkIs4F1YnxFr%2BF6LUhRAi%2FQxP3%2FSlBdmt8PDzMSlWy8mzutqLF2GSqZvlSl0CVpinEfQv03EuXd7Se7%2Fl3nQaNqrYw4bWH7xLZfUJ9u0H7os8Vm5qlwo%2BpgtWofr5%2B0fC2ULjCx%2BQFiQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca0a59d29b46-FRA
expires: Wed, 13 Sep 2023 17:24:34 GMT

GET
H2 200 Mini-mag-EPR.png
www.europeanpharmaceuticalreview.com/wp-content/uploads/ 63 KB
63 KB 20ms
20ms Image
image/webp 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Mini-mag-EPR.png

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4175a866357b02948f152ab64866ffb7f2aafcd5882b6ea2ab889c08726626c1

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 118885
cf-polished: origFmt=png, origSize=85382
content-disposition: inline; filename="Mini-mag-EPR.webp"
content-length: 64256
cf-bgj: imgq:100,h2pri
last-modified: Mon, 04 Sep 2023 15:00:18 GMT
server: cloudflare
vary: Accept
x-frame-options: SAMEORIGIN
content-type: image/webp
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=rT3o1UZP%2FCx5g82Chzu4Xgkrl2UFYgx8kwMc4Ap4eUN40yfJes9m1oK%2F9n%2FXwPY1GHO6HnYpV0Djoi7VckANv%2F1GGsr4L8o%2F8%2BnZ1qFkYjJ%2FhPmBPFvgxE%2BOsgGiSQv4MBAix7MYMUzaPT9Qv3qDDEfofVrnOAQyozKqzlWx3TJXSg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca0a59d39b46-FRA
expires: Tue, 12 Sep 2023 09:00:30 GMT

GET
H2 200 ;ID=167548;size=728x90;setID=291841;type=async;domid=placement_291841_0;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33... Show response
servedbyadbutler.com/adserve/ 927 B
918 B 17ms
15ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=728x90;setID=291841;type=async;domid=placement_291841_0;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

cc6a070341f6c03aaac68c47067dd5f5629e6a7eb5b22dbafad7b53830c828b5

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x123;setID=375052;type=async;domid=ad27;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-... Show response
servedbyadbutler.com/adserve/ 915 B
913 B 17ms
15ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x123;setID=375052;type=async;domid=ad27;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

a222f393763fe4813aae036c1793bcd7422d39db10415f47ef297b274e70b947

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=210x900;setID=255245;type=async;domid=ad1;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 890 B
906 B 18ms
16ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=210x900;setID=255245;type=async;domid=ad1;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

6f1c6db27477e74d8c721077c8da5096006d8c5f0d8144b7ddb1ad10c435ac92

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=970x90;setID=297599;type=async;domid=11;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vac... Show response
servedbyadbutler.com/adserve/ 891 B
903 B 20ms
19ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=970x90;setID=297599;type=async;domid=11;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

32ebf8f5f16af1400e9bdd97ce67f27b20219da4920086ca4365014c737c20f5

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=728x90;setID=198544;type=async;domid=15;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vac... Show response
servedbyadbutler.com/adserve/ 129 B
407 B 19ms
17ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=728x90;setID=198544;type=async;domid=15;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

cf629ea2a78255c90faaef3c4a206b48b608f0d302f8704f45e26005cf9a7aa6

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=297597;type=async;domid=ad8;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 896 B
908 B 16ms
15ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=297597;type=async;domid=ad8;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

5d3e035104a91cf73399fee4e2b0c7c5341f2183ede962b29d0d62cae31d4a57

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=203205;type=async;domid=ad4;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 894 B
905 B 18ms
17ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=203205;type=async;domid=ad4;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

af7ec4a5a1c1a3284cccf2fb2cb66721693795d7e37dfe6fbb54439a1e31baaa

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=203206;type=async;domid=ad5;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 910 B
915 B 18ms
17ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=203206;type=async;domid=ad5;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

ac854adf2992b4e4e4418bb689417ee2b0ac643f2069e1ada14c4bdf1c71297b

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=297595;type=async;domid=ad6;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 892 B
909 B 16ms
15ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=297595;type=async;domid=ad6;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

83287a12d21cfaff8bec28bed69c0a77db4bbf689eb609046fc83e84d4eae41d

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=297596;type=async;domid=ad7;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 130 B
408 B 13ms
12ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=297596;type=async;domid=ad7;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

535d2ecb691ed2d1199ee74b19e72fdd5724f8682980f9820db61024eb32cc8f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x250;setID=297598;type=async;domid=ad9;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 903 B
911 B 19ms
18ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x250;setID=297598;type=async;domid=ad9;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

ba51d8f85784fb67039473299849fd954a076e8f809a26cc0ec099fd79f56056

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=300x100;setID=202948;type=async;domid=ad10;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-... Show response
servedbyadbutler.com/adserve/ 131 B
409 B 17ms
17ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=300x100;setID=202948;type=async;domid=ad10;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

2f0bfb991a34c2622f74df2de3c63f5782ec9e297dc6d2e130d456a0411f9bd4

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H2 200 ;ID=167548;size=210x900;setID=255246;type=async;domid=ad2;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-v... Show response
servedbyadbutler.com/adserve/ 890 B
906 B 19ms
18ms Script
application/javascript 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://servedbyadbutler.com/adserve/;ID=167548;size=210x900;setID=255246;type=async;domid=ad2;place=0;pid=1225560;sw=1600;sh=1200;spr=1;rnd=1225560;referrer=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F;atf=1;click=CLICK_MACRO_PLACEHOLDER

Requested by

Host: servedbyadbutler.com
URL: https://servedbyadbutler.com/app.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),

Reverse DNS

static.61.246.55.162.clients.your-server.de

Software

nginx /

Resource Hash

d06528b8fc8644ed639df5ca7863c353785c73629c5f7739d9a6f430882d532f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: nginx
vary: Accept-Encoding
p3p: CP="ALL DSP COR CUR ADMi DEVi CONi TELi OUR BUS UNI PRE"
content-type: application/javascript
access-control-allow-origin: *
cache-control: post-check=0, pre-check=0
access-control-allow-credentials: true
expires: Mon, 26 Jul 1997 05:00:00 GMT

POST
H2 200 8028ca03c88b9b46 Show response
www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/jsd/r/ Frame 219E 0
507 B 28ms
27ms XHR
text/plain 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/h/g/jsd/r/8028ca03c88b9b46
Requested by: Host: www.europeanpharmaceuticalreview.com
URL: https://www.europeanpharmaceuticalreview.com/cdn-cgi/challenge-platform/scripts/jsd/main.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/json

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
content-encoding: br
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 8028ca0b0adb9b46-FRA
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DzklJTDxQWBzNtzcTBXUZfLPrMC7vY5wa33NPPlE0E6e7cPYh9dkX%2FNKAWlmrHiKrvhULivn6W1mLg6YfOymsiNDQKOst97Hh8fRd%2F3PuLNEtDq9SmdGDV%2BZqzedV%2BOguzIYS%2Bc6Sya9aZvdDVHyJ2spR0fZLv%2BLKCa4UTbWanxH%2BQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/plain; charset=UTF-8

GET
H3 200 analytics.js Show response
www.google-analytics.com/ 52 KB
21 KB 9ms
8ms Script
text/javascript 2a00:1450:4001:831::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-10556842-6&l=dataLayer&cx=c

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
date: Wed, 06 Sep 2023 17:49:43 GMT
last-modified: Mon, 12 Jun 2023 18:23:07 GMT
server: Golfe2
age: 2506
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=7200
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 20994
expires: Wed, 06 Sep 2023 19:49:43 GMT

GET
H2 200 ebola-MVA-BN-Filo-300x210.jpg
www.europeanpharmaceuticalreview.com/wp-content/uploads/ 15 KB
15 KB 52ms
48ms Image
image/jpeg 2606:4700:3108::ac42:2bbe
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.europeanpharmaceuticalreview.com/wp-content/uploads/ebola-MVA-BN-Filo-300x210.jpg

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3108::ac42:2bbe , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1b73e09135d556a9c4f2d67d9f6430bf9cd6ebd8447515758742420d748aa911

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-polished: status=not_needed
content-length: 15487
cf-bgj: imgq:100,h2pri
last-modified: Sat, 30 Apr 2016 18:45:50 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bsFJwPjTJ29k1fIQjEtOfP90Ag5aAZDtqAdQmuxxfx8VC00a5M%2BulC8XkTll%2Fp90BmnLYlPGUcKhyUCqdzl%2BjoYT0TMfpc3OLrYSGalfA4YhfsOy9WCmTU39oHJ8y12T%2F4MKVFaw5WW0hMxHDcznPfpTkh58dOzZqpysEtzmZuFiOw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
vary: Accept-Encoding
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
cf-ray: 8028ca0b4b3e9b46-FRA
expires: Wed, 13 Sep 2023 17:24:34 GMT

GET
H3 200 anchor Show response
www.google.com/recaptcha/api2/ Frame 5073 54 KB
30 KB 38ms
37ms Document
text/html 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&co=aHR0cHM6Ly93d3cuZXVyb3BlYW5waGFybWFjZXV0aWNhbHJldmlldy5jb206NDQz&hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1&size=invisible&cb=xmyt06lwuv62

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

088c59c0681bbbd4611e91fd527060c257ad3680f0d799e9b783a858fc483d2f

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-8w2puLaZ8DdILk9wUNpEEA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.europeanpharmaceuticalreview.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-length: 30770
content-security-policy: script-src 'report-sample' 'nonce-8w2puLaZ8DdILk9wUNpEEA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 06 Sep 2023 18:31:29 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H2 200 web Show response
onesignal.com/api/v1/sync/1a412ad1-717d-44b4-b32e-c330d83223d6/ 3 KB
2 KB 26ms
23ms Script
text/javascript 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://onesignal.com/api/v1/sync/1a412ad1-717d-44b4-b32e-c330d83223d6/web?callback=__jp0

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151604

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e8db51ce4c14ff5417396b03f3a5eca97fd1f2682bbfdb54acf80bafa95852e7

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
via: 1.1 google
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: br
x-permitted-cross-domain-policies: none
strict-transport-security: max-age=15552000; includeSubDomains
age: 1325
cf-polished: origSize=3490
alt-svc: h3=":443"; ma=86400
x-xss-protection: 1; mode=block
x-request-id: 3fa33730-d15a-4b06-97e2-f41babe1d3ad
x-runtime: 0.031377
referrer-policy: strict-origin-when-cross-origin
cf-bgj: minify
server: cloudflare
etag: W/"a70c778140c29046886f24957878795c"
x-download-options: noopen
vary: Origin, Accept-Encoding
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=3600
cf-ray: 8028ca0bb9bb5c98-FRA
access-control-allow-headers: SDK-Version
expires: Wed, 06 Sep 2023 19:31:29 GMT

GET
H3 200 /
www.google.com/pagead/1p-user-list/964653157/ 42 B
64 B 46ms
45ms Image
image/gif 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/pagead/1p-user-list/964653157/?random=1694025089413&cv=11&fst=1694023200000&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&value=replace%20with%20value&data=event%3Dpage_view%3Bgoogle_business_vertical%3Dcustom%3Bid%3Dreplace%20with%20value%3Blocation_id%3Dreplace%20with%20value&fmt=3&is_vtc=1&random=1735255101&rmt_tld=0&ipr=y

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-security-policy: script-src 'none'; object-src 'none'
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 /
www.google.gr/pagead/1p-user-list/964653157/ 42 B
64 B 25ms
25ms Image
image/gif 2a00:1450:4001:831::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.gr/pagead/1p-user-list/964653157/?random=1694025089413&cv=11&fst=1694023200000&bg=ffffff&guid=ON&async=1&gtm=45be38u0&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F33350%2Foxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov%2F&frm=0&tiba=Phase%202%20study%20of%20MVA-BN-Filo%20and%20Ad26.ZEBOV%20starts&value=replace%20with%20value&data=event%3Dpage_view%3Bgoogle_business_vertical%3Dcustom%3Bid%3Dreplace%20with%20value%3Blocation_id%3Dreplace%20with%20value&fmt=3&is_vtc=1&random=1735255101&rmt_tld=1&ipr=y

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 06 Sep 2023 18:31:29 GMT
content-security-policy: script-src 'none'; object-src 'none'
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ;libID=3924021
servedbyadbutler.com/getad.img/ 72 KB
72 KB 10ms
10ms Image
image/jpeg 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3924021
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 8632413702d41d0dfcd1b7037b0aaf256af0a0318462ea217f4647e6f7037055

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:46:06 GMT
server: nginx
etag: "64f1263e-11e33"
content-type: image/jpeg
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="dpl_banner_footer_gluconates_728x90px-v01.jpg"
accept-ranges: bytes
content-length: 73267
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/ Frame 5073 55 KB
24 KB 33ms
11ms Stylesheet
text/css 2a00:1450:4001:806::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&co=aHR0cHM6Ly93d3cuZXVyb3BlYW5waGFybWFjZXV0aWNhbHJldmlldy5jb206NDQz&hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1&size=invisible&cb=xmyt06lwuv62

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:806::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 07:59:26 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 37923
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 21 Aug 2023 02:02:34 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 05 Sep 2024 07:59:26 GMT

GET
H3 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/ Frame 5073 454 KB
182 KB 32ms
11ms Script
text/javascript 2a00:1450:4001:806::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/recaptcha__de.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:806::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

587fc1c1e943e8763bd2e2ff0be4a0e5efc61181b1a4834c99aac812c5c126a0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:10:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 1235
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 186637
x-xss-protection: 0
last-modified: Mon, 21 Aug 2023 02:02:34 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 05 Sep 2024 18:10:54 GMT

GET
H2 200 ;libID=3839348
servedbyadbutler.com/getad.img/ 66 KB
66 KB 10ms
9ms Image
image/jpeg 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3839348
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: dc8276f14c8c80382fe030dfae4fb34e503d5e3557a54e1793fa5c6bc5d6001e

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Wed, 17 May 2023 12:55:56 GMT
server: nginx
etag: "6464cedc-107be"
content-type: image/jpeg
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="EPR - Email Sign-up 25.jpg"
accept-ranges: bytes
content-length: 67518
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3934833
servedbyadbutler.com/getad.img/ 134 KB
134 KB 16ms
16ms Image
image/gif 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3934833
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: bc1ee17c223d2645e9e2946eeca21fcfc620b5e1addee2524f1bfeb82f900467

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:15:19 GMT
server: nginx
etag: "64f11f07-216fb"
content-type: image/gif
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="GEA_Sept_2023_EPR_210x900-L1.gif"
accept-ranges: bytes
content-length: 136955
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3933572
servedbyadbutler.com/getad.img/ 591 KB
592 KB 21ms
21ms Image
image/gif 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3933572
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 2a6f4516c89cb4a7acbd6470b9dd282bb2332266de8a394d4ecb56c8bf7ed9dc

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:46:06 GMT
server: nginx
etag: "64f1263e-93c0f"
content-type: image/gif
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="44525_Milliflex_Rapid_animated_GIF_EPR_display_banner_970x90_MSIG_FNL.gif"
accept-ranges: bytes
content-length: 605199
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3923884
servedbyadbutler.com/getad.img/ 55 KB
55 KB 22ms
22ms Image
image/png 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3923884
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 6ab9e406e592c81d9d01d0117cf7ba1e796046d7193493baf6f70feee258a56c

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:27:16 GMT
server: nginx
etag: "64f121d4-dc3e"
content-type: image/png
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="APPROVED 2023 GIL-3396 EPR Web banner Sept .png"
accept-ranges: bytes
content-length: 56382
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3938940
servedbyadbutler.com/getad.img/ 31 KB
32 KB 22ms
21ms Image
image/gif 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3938940
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: a3b6ab755795c30c7cdfa86b65120df5170d6d5b27454a852202e9cec31d2d89

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Fri, 01 Sep 2023 07:50:21 GMT
server: nginx
etag: "64f197bd-7d49"
content-type: image/gif
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="RT-AD158_Nebula-Absorbance-Reader_300x250_animated.gif"
accept-ranges: bytes
content-length: 32073
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3926206
servedbyadbutler.com/getad.img/ 237 KB
237 KB 28ms
28ms Image
image/png 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3926206
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 406e6eeb36760f531d26f581964feecce21ec71f15d06ce7f17380d7339113e8

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:14:17 GMT
server: nginx
etag: "64f11ec9-3b309"
content-type: image/png
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="300x250_Unrelenting_campaign.png"
accept-ranges: bytes
content-length: 242441
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3924998
servedbyadbutler.com/getad.img/ 128 KB
128 KB 28ms
28ms Image
image/jpeg 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3924998
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: ed2516f391792da401a9be67a828efd5d1853b94571d7b824dbf1dfcfdbb5e90

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:15:19 GMT
server: nginx
etag: "64f11f07-1fe11"
content-type: image/jpeg
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="ACC-PSNG-ItsEasyToSee-300x250-BannerAd113022copy.jpg"
accept-ranges: bytes
content-length: 130577
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=751302
servedbyadbutler.com/getad.img/ 377 KB
377 KB 29ms
26ms Image
image/jpeg 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=751302
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: 3e74ab450ca92d8cdf45082278993ddd32c3e90901d65dd51c51d5a607c11296

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Sat, 23 Oct 2021 20:04:58 GMT
server: nginx
etag: "61746aea-5e269"
content-type: image/jpeg
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="300x250.jpg"
accept-ranges: bytes
content-length: 385641
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H2 200 ;libID=3934834
servedbyadbutler.com/getad.img/ 145 KB
146 KB 29ms
26ms Image
image/gif 162.55.246.61
HETZNER-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://servedbyadbutler.com/getad.img/;libID=3934834
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 162.55.246.61 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS: static.61.246.55.162.clients.your-server.de
Software: nginx /
Resource Hash: ce55bc99e72635134b52b67a2092468d366fce524b0902077b94a7ea39a5bded

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
last-modified: Thu, 31 Aug 2023 23:15:19 GMT
server: nginx
etag: "64f11f07-24535"
content-type: image/gif
access-control-allow-origin: https://www.europeanpharmaceuticalreview.com
cache-control: max-age=31536000
access-control-allow-credentials: true
content-disposition: inline; filename="GEA_Sept_2023_EPR_210x900_R1.gif"
accept-ranges: bytes
content-length: 148789
expires: Thu, 05 Sep 2024 11:31:29 PDT

GET
H3 200 OneSignalSDKStyles.css
onesignal.com/sdks/ 82 KB
9 KB 27ms
26ms Stylesheet
text/css 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://onesignal.com/sdks/OneSignalSDKStyles.css?v=2

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151604

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

db7e0b393e175f19922fefbdcaa2866fca209c521d01cc834ae06cbf8d0f91b7

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:29 GMT
via: 1.1 google
content-encoding: br
cf-cache-status: HIT
server: cloudflare
strict-transport-security: max-age=15552000; includeSubDomains
age: 1998
etag: W/"4e9aaefffd5f8ae7dc83361aa2294190"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=2592000
cf-ray: 8028ca0c4ee81983-FRA
access-control-allow-headers: OneSignal-Subscription-Id
alt-svc: h3=":443"; ma=86400
expires: Fri, 06 Oct 2023 18:31:29 GMT

GET
H3 200 logo_48.png
www.gstatic.com/recaptcha/api2/ Frame 5073 2 KB
2 KB 8ms
7ms Image
image/png 2a00:1450:4001:806::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.gstatic.com/recaptcha/api2/logo_48.png

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/styles__ltr.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:806::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

1b9efb22c938500971aac2b2130a475fa23684dd69e43103894968df83145b8a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/styles__ltr.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 01:27:29 GMT
x-content-type-options: nosniff
age: 61441
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2228
x-xss-protection: 0
last-modified: Tue, 03 Mar 2020 20:15:00 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
expires: Wed, 13 Sep 2023 01:27:29 GMT

GET
H2 200 KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 5073 15 KB
15 KB 9ms
8ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.google.com/
Origin: https://www.google.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Sat, 02 Sep 2023 08:35:58 GMT
x-content-type-options: nosniff
age: 381332
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15344
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:32:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 01 Sep 2024 08:35:58 GMT

GET
H2 200 KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 5073 15 KB
15 KB 8ms
8ms Font
font/woff2 2a00:1450:4001:801::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOlCnqEu92Fr1MmEU9fBBc4.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:801::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.google.com/
Origin: https://www.google.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Tue, 05 Sep 2023 17:41:40 GMT
x-content-type-options: nosniff
age: 89390
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15552
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:33:02 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Wed, 04 Sep 2024 17:41:40 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame 5073 102 B
134 B 22ms
21ms Other
text/javascript 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

c548ab92911cb0c3db4cbbe04248ddbfd4f50759d33b73ba54f6086cb7716b68

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&co=aHR0cHM6Ly93d3cuZXVyb3BlYW5waGFybWFjZXV0aWNhbHJldmlldy5jb206NDQz&hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1&size=invisible&cb=xmyt06lwuv62
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:30 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 112
x-xss-protection: 1; mode=block
expires: Wed, 06 Sep 2023 18:31:30 GMT

POST
H3 200 reload Show response
www.google.com/recaptcha/api2/ Frame 5073 32 KB
19 KB 62ms
61ms XHR
application/json 2a00:1450:4001:803::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/reload?k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/0hCdE87LyjzAkFO5Ff-v7Hj1/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

80f3cd533d51b52615070047f26baf82f1883577822eb11e2dc51a96c86cfd95

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcNg4AUAAAAAICRM395SnX0ksnVGa2nEdZfnxOz&co=aHR0cHM6Ly93d3cuZXVyb3BlYW5waGFybWFjZXV0aWNhbHJldmlldy5jb206NDQz&hl=de&v=0hCdE87LyjzAkFO5Ff-v7Hj1&size=invisible&cb=xmyt06lwuv62
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36
Content-Type: application/x-protobuffer

Response headers

date: Wed, 06 Sep 2023 18:31:30 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: application/json; charset=utf-8
cache-control: private, max-age=0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 19008
x-xss-protection: 1; mode=block
expires: Wed, 06 Sep 2023 18:31:30 GMT

GET
H3 200 icon Show response
onesignal.com/api/v1/apps/1a412ad1-717d-44b4-b32e-c330d83223d6/ 184 B
757 B 96ms
84ms Fetch
application/json 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://onesignal.com/api/v1/apps/1a412ad1-717d-44b4-b32e-c330d83223d6/icon

Requested by

Host: cdn.onesignal.com
URL: https://cdn.onesignal.com/sdks/OneSignalPageSDKES6.js?v=151604

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6169519942b5056579e986436587603b508670d9db194258d453db93c0e10e83

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

date: Wed, 06 Sep 2023 18:31:31 GMT
via: 1.1 google
x-content-type-options: nosniff
cf-cache-status: REVALIDATED
content-encoding: br
x-permitted-cross-domain-policies: none
strict-transport-security: max-age=15552000; includeSubDomains
alt-svc: h3=":443"; ma=86400
x-xss-protection: 1; mode=block
x-request-id: 3c6a4b69-601c-4a65-b9d1-6a3535582789
x-runtime: 0.015512
referrer-policy: strict-origin-when-cross-origin
server: cloudflare
etag: W/"6169519942b5056579e986436587603b"
x-download-options: noopen
x-frame-options: SAMEORIGIN
vary: Accept, Origin, Accept-Encoding
content-type: application/json; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=0, private, must-revalidate
cf-ray: 8028ca13e8504d50-FRA
access-control-allow-headers: SDK-Version

GET
H2 200 95eeda54-cf76-496c-bf67-6b4a7526c197
img.onesignal.com/permanent/ 10 KB
11 KB 94ms
77ms Image
application/octet-stream 2606:4700::6812:d73b
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://img.onesignal.com/permanent/95eeda54-cf76-496c-bf67-6b4a7526c197

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:d73b , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e9ae795603fcb77ad3373c66ad4f06849a0c86fa557c223762e29fd66ed08009

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.europeanpharmaceuticalreview.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.179 Safari/537.36

Response headers

x-goog-encryption-kms-key-name: projects/core-infra-onesignal/locations/europe-west4/keyRings/keyring-kms-onesignal/cryptoKeys/img-persistence-bucket-onesignal/cryptoKeyVersions/1
date: Wed, 06 Sep 2023 18:31:31 GMT
strict-transport-security: max-age=15552000; includeSubDomains
cf-cache-status: REVALIDATED
x-guploader-uploadid: ADPycdtaI1kn2v7BXBQlKpefqzOA9SReI5iUeW307Sr-1dha3qQnRYR1jBwN58iFzMQeko5fZPWrFley9KuS87OV9jKz6g
x-goog-meta-x-goog-source-etag: "798842248286ea2def7aebd74b3779f9"
x-goog-storage-class: STANDARD
x-goog-metageneration: 1
x-goog-stored-content-encoding: identity
alt-svc: h3=":443"; ma=86400
content-length: 10145
pragma: no-cache
last-modified: Tue, 14 Feb 2023 03:41:22 GMT
server: cloudflare
etag: "-CJrH+uWLlP0CEAE="
vary: Origin, Accept-Encoding
x-goog-generation: 1676346082108314
content-type: application/octet-stream
x-goog-hash: crc32c=G7icoQ==, md5=eYhCJIKG6i3veuvXSzd5+Q==
cache-control: public, max-age=2678400
x-goog-meta-cache-control: public, maxage=604800
x-goog-stored-content-length: 10145
accept-ranges: bytes
cf-ray: 8028ca14cdcd5c98-FRA
expires: Sat, 07 Oct 2023 18:31:31 GMT

Verdicts & Comments Add Verdict or Comment

236 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

28 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
www.google.com/recaptcha	1970-01-20 18:52:57	Name: _GRECAPTCHA Value: 09AGruPJaMgpmSHMlKtushKq1nRm0sQYkua-MMf0X-T820ctT3niFyyJQvXM9CFszOPVOUZUbi7M3pHjtD3Z8V7V4
.europeanpharmaceuticalreview.com/	1970-01-20 14:35:11	Name: _gid Value: GA1.2.1817675551.1694025089
.europeanpharmaceuticalreview.com/	1970-01-20 14:33:45	Name: _gat Value: 1
.europeanpharmaceuticalreview.com/	1970-01-20 23:19:21	Name: cf_clearance Value: 8WgO2B._z4zqQmHwUMS0k7ntIOiWxuvYxZ85m0Y2yig-1694025089-0-1-99b8db3d.698e75ff.ceb984dd-0.2.1694025089
.onesignal.com/	1970-01-20 14:33:46	Name: __cf_bm Value: woG1pEOMCSGCybzyp24NZBS.cBXXsNLS.zaspPtjHsg-1694025089-0-AQ/pb4MqXPh9USGfGDID/PCgY3aKuKcZsYbb5LYZ+53aFn/WSh+QZf34fegcyFyx2SMykO1Ydz7ODpspM/F/iV8=
.europeanpharmaceuticalreview.com/	1970-01-21 00:09:45	Name: _ga_H1P066ENQD Value: GS1.2.1694025089.1.0.1694025089.60.0.0
www.europeanpharmaceuticalreview.com/	1970-01-21 00:09:45	Name: advanced_ads_page_impressions Value: %7B%22expires%22%3A1757097089%2C%22data%22%3A1%7D
.europeanpharmaceuticalreview.com/	1970-01-20 16:43:21	Name: _gcl_au Value: 1.1.545148852.1694025089
.europeanpharmaceuticalreview.com/	1970-01-21 00:09:45	Name: _ga_Y65RLNHTF0 Value: GS1.1.1694025089.1.0.1694025089.60.0.0
.doubleclick.net/	1970-01-20 14:33:45	Name: test_cookie Value: CheckForPermission
www.europeanpharmaceuticalreview.com/	1970-01-20 15:16:57	Name: advanced_ads_browser_width Value: 1600
www.europeanpharmaceuticalreview.com/	1970-01-20 18:55:49	Name: cookielawinfo-checkbox-necessary Value: yes
www.europeanpharmaceuticalreview.com/	1970-01-20 18:55:49	Name: cookielawinfo-checkbox-performance Value: yes
www.europeanpharmaceuticalreview.com/	1970-01-20 18:55:49	Name: cookielawinfo-checkbox-analytics Value: yes
www.europeanpharmaceuticalreview.com/	1970-01-20 18:55:49	Name: cookielawinfo-checkbox-advertising-targeting Value: yes
www.europeanpharmaceuticalreview.com/	1970-01-20 14:35:11	Name: ln_or Value: eyIzMDQwNDIiOiJkIn0%3D
www.europeanpharmaceuticalreview.com/	1970-01-21 00:09:45	Name: wow.anonymousId Value: a7c331e2-5a37-40f2-a77a-808779de6244
www.europeanpharmaceuticalreview.com/	1970-01-20 14:33:46	Name: wow.schedule Value: wowTracking_2
www.europeanpharmaceuticalreview.com/	1970-01-20 14:33:46	Name: wow.session Value: a7c331e2-5a37-40f2-a77a-808779de6244
www.europeanpharmaceuticalreview.com/	1970-01-20 14:33:46	Name: wow.utmvalues Value:
.linkedin.com/	1970-01-20 16:43:21	Name: li_sugr Value: 9af795a3-de55-400f-9496-4281e9cbcdbc
.linkedin.com/	1970-01-20 23:19:21	Name: bcookie Value: "v=2&d23fa3c2-c2ce-47a7-83ca-974031cc0ecb"
.linkedin.com/	1970-01-20 14:35:11	Name: lidc Value: "b=TGST01:s=T:r=T:a=T:p=T:g=3126:u=1:x=1:i=1694025089:t=1694111489:v=2:sig=AQFqQK9tQp5wFkk6VODCGnRzOnHiKmWO"
.europeanpharmaceuticalreview.com/	1970-01-21 00:09:45	Name: _ga Value: GA1.2.1717306311.1694025089
.linkedin.com/	1970-01-20 15:16:57	Name: UserMatchHistory Value: AQLjEnY4F_0P6AAAAYprw4Nj_0Me6gX-RJ8bx8DI3tLB0ORWposgGCiUlRgH4gqoNNSyM46TKrwjLQ
.linkedin.com/	1970-01-20 15:16:57	Name: AnalyticsSyncHistory Value: AQLSxqZ6VJthzwAAAYprw4Nj_qz1abfFNdfVCZcDG4znboZSQkbPcm9Y4aRL7VrxQysiy1Qsk0QDHFLHDUPLDw
.www.linkedin.com/	1970-01-20 23:19:21	Name: bscookie Value: "v=1&2023090618313053f718e2-8b09-41b1-8ed4-0c4703419e57AQEkX6Ne9tNVUmTECHS8GYWbyGcCAO39"
.linkedin.com/	1970-01-20 18:52:57	Name: li_gc Value: MTswOzE2OTQwMjUwOTA7MjswMjH7Uw8ek9cX3FbXBd6ozNpikmPqoUUSIxgGRLDVm701xw==

2 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
javascript	warning	URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/ Message: The resource https://fonts.googleapis.com/css?family=Muli:300,300i,400,400i,600&display=swap was preloaded using link preload but not used within a few seconds from the window's load event. Please make sure it has an appropriate `as` value and it is preloaded intentionally.
javascript	warning	URL: https://www.europeanpharmaceuticalreview.com/news/33350/oxford-vaccine-group-initiates-phase-2-study-of-ebola-prime-boost-vaccine-regimen-combining-mva-bn-filo-and-ad26-zebov/ Message: The resource https://fonts.googleapis.com/css?family=Titillium+Web:300,400,600&display=swap was preloaded using link preload but not used within a few seconds from the window's load event. Please make sure it has an appropriate `as` value and it is preloaded intentionally.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Frame-Options	SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

cdn.linkedin.oribi.io
cdn.mathjax.org
cdn.onesignal.com
cdnjs.cloudflare.com
fonts.googleapis.com
fonts.gstatic.com
googleads.g.doubleclick.net
idx.liadm.com
img.onesignal.com
maxcdn.bootstrapcdn.com
onesignal.com
px.ads.linkedin.com
px4.ads.linkedin.com
region1.analytics.google.com
secure.leadforensics.com
servedbyadbutler.com
snap.licdn.com
static.cloudflareinsights.com
stats.g.doubleclick.net
t.gatorleads.co.uk
t.wowanalytics.co.uk
use.fontawesome.com
www.europeanpharmaceuticalreview.com
www.google-analytics.com
www.google.com
www.google.gr
www.googleoptimize.com
www.googletagmanager.com
www.gstatic.com
www.linkedin.com
13.107.42.14
162.55.246.61
2001:4860:4802:32::36
2600:9000:20eb:8000:2:53b2:240:93a1
2606:4700:20::681a:cdc
2606:4700:3108::ac42:2bbe
2606:4700::6810:3965
2606:4700::6811:180e
2606:4700::6812:acf
2606:4700::6812:d73b
2606:4700:e0::ac40:660b
2620:1ec:21::14
2a00:1450:4001:801::2003
2a00:1450:4001:803::2004
2a00:1450:4001:806::2003
2a00:1450:4001:808::200a
2a00:1450:4001:80e::2008
2a00:1450:4001:811::2002
2a00:1450:4001:82b::200e
2a00:1450:4001:831::2003
2a00:1450:4001:831::200e
2a00:1450:400c:c0c::9a
2a02:26f0:480:f::213:7ec6
37.221.223.17
37.221.223.30
51.140.49.131
52.204.63.111
028b3be727cbed0ee4e0c9a67c5a1991d8997ca97ecfbf830c448cb7730e22df
029e0a2e809fd6b5dbe76abe8b7a74936be306c9a8c27c814c4d44aa54623300
045623753f6ec51bc4797e3d69d3b23459bd4447bb16c994e56454fef1488c66
04c1bc744720c6e7542613e933c9a0f4bbd8f6ed45a5b1924223c256430dfd7b
05c78d6a2624f38e659dfad31d402bbda31897361e2ea1a4ef04bd1e78d41b85
0652f37cb87881481399eae1bd2e005378b6ba663c27efc285ade4832f428035
07556f378e5523136e2c6e0197ed545fa18f9f7022c83a93eac10ea24533bcfa
088c59c0681bbbd4611e91fd527060c257ad3680f0d799e9b783a858fc483d2f
09633800cece83fb2340dca614d3089892ead37c8a535cee4519995d7340d167
0ba2a0da5c4bbb91065d70e8d6e9e22b1eb1c2e066ac876e261efcc96036b031
0c737a04714a47dbf09c3ccb803aa43f0fc6d3fd0ffd70aaba05ff9580b63750
0c9aca2a71cdfe5e8e4eeed187dc802909e67482e63d1c3642d75e9f3067c8e7
13031d4ec04980984b56e9152739c608e15fcda23007e524117198f054385eb6
131109318044868d0e193e1ce55d355b0f75ee31e84d89630017c4f92f85d13d
16a58c953e842b2c6d7e9df0be63f988c6d27e026316a1fd00e6ce1a6d861e96
196797bf8fe4e7183756b1400cdd9c06802f69d6d9c01942f8bfa570e7bd8c19
196b0d1013a5fb1985890e13453ab76df8bdcee3d57893e84afa3f3e58eacf52
1a4dd11c3764a3be7caee75eeb660be2d9f01fc3ba61f95990d8f64e5e441875
1b73e09135d556a9c4f2d67d9f6430bf9cd6ebd8447515758742420d748aa911
1b9efb22c938500971aac2b2130a475fa23684dd69e43103894968df83145b8a
1c1fef6e6b4f9832603850b9b6562e74d9a6a3700ba836efe88facc577121e8b
1cd82d0cdc1913fa55a51736475fd9ff3f392c5c19e92186b94b370be719c5c9
204940afe9760586b383ef2b85e74853600ad372d219e0e5fab792531843f64a
23134fb54459872d99152d55ffa65a9e6858bdb4fa6ed262f727f4dc78c4e19b
23bb39b607b39a93d953762d2a618a3cbc69c52ceaf70d96890137ca1d2b0228
2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8
2648a1333fa24d383fd73a6beaac17156ae78f4267ff7407ad60e05a788df44c
2793a7736c4421efb5ec1f639c9b19a081a6b7a91097d4459149fab67c47b9ae
279a4286b060df1ef8d319db605518469c2f221633e99328cdac27a895fcdf7b
28a26321734fb5f8c8fe42b5503f162fdf1469bf97e2d9c503a83cc2b3c534cd
29a09388a9bacf4e7217bdac10fcd407c24096c882bb3eeeeab54d0e5fc78900
2a04078f9550381b5148170ceaf5b378a1b31ed8274c6d0094aeba6f599462cc
2a6f4516c89cb4a7acbd6470b9dd282bb2332266de8a394d4ecb56c8bf7ed9dc
2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe
2ee9b48ac5728cc661fe785e8b01598239eb16bb62f9fe1f759a36568826fbdc
2f0bfb991a34c2622f74df2de3c63f5782ec9e297dc6d2e130d456a0411f9bd4
303a3183beb25d87b4b551609af6d46c4c5743b5fcd01f73469a4d70a224dbb0
32ebf8f5f16af1400e9bdd97ce67f27b20219da4920086ca4365014c737c20f5
378960341d22bd9b3e9c3843eff3ea319707448fbd9bbae7517f20509c33ca66
3a86cdada5e5a31807176f2881b5b196dedbec52d01a47865d9ccbf6f8e33f23
3d16a5a4e863b0910ad953b325725fdb82cf8a8055db033e9925cf255b8551ad
3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc
3e74ab450ca92d8cdf45082278993ddd32c3e90901d65dd51c51d5a607c11296
3eb2861edb732eb23c1000b154b8fcb87a47320fe43b815911379ff3f26f60db
3fe890d088ecf0cc9bc1b9069201e52972dbad6237865524090e15982d0de718
400338a215884d3cdd5345fc80e7b77f76bec4b0ec779de8730e958b7c578f1c
406e6eeb36760f531d26f581964feecce21ec71f15d06ce7f17380d7339113e8
4175a866357b02948f152ab64866ffb7f2aafcd5882b6ea2ab889c08726626c1
425197a561a2dc98259d7e284f708115b672f426a8adc0955f6f42fbaa61d7ae
435d55dcce5dd9e7f92ba076d669ff729228204358fa196158c3c2b2a983b727
442a93bc4ed53ff731192cbbba04a75d370ff795faca04d06b2aaa83afd1b48a
4471f0e0712693e37d562bb4981a7da17248062fc39140f3df05826943879fb7
453893f7daa3d8fe9716f8c6d0f36f8ade8cacfc0093e164f4f998b46427959e
479d0d0dc75842e56660bc544203c45f12c9efd8c598f66f494dcca691a3d24e
4c78cb8dfcc1a971c55b0bc87cdbf4bf0a4417e5c9726f1a6952ca3932acb704
509e8b786e3475eaaa81f8103e1017372c00b21dd992373faf5ca6dd7a6f358b
52f1242ce4333ced64463347687a7280e2ac3d2e4f4cd340b9fcaabe73761af1
535d2ecb691ed2d1199ee74b19e72fdd5724f8682980f9820db61024eb32cc8f
54169b42e428d60f4cc305c5006e0883e193dc636054a49eb2d51f1641289646
542aa3a659dae23a91406e12842f7c1554e955238427f8374c6a1e17bfdb1940
54d15b2e78fa2ccedc59339be094ad2dc7cde526b05c8365ce661b695f59cb16
557f6d0883db85be712c3a77baa38875ddf99ecbdfd6fec98e5c0b1f7a0e1532
578332cd14c1c8f1c9ea7cc966ca50ae73945b7de3055e07f06dc099d4feeee0
5841eb6d1895c740317d98a4cd9e5aeced865f5c50182647401afc3d303367e1
587fc1c1e943e8763bd2e2ff0be4a0e5efc61181b1a4834c99aac812c5c126a0
58db26f0b52386b86a7d668b47bce73d1faaf9a0b8beb57069a63ba28f36c9af
59848acc8f86a05b6983df9f54056ec156e969186ac5ac2b723b57303143bc7b
599fc36cdbfa2e704431b32f80c0da4d9f1207860923856f9aaf94ec34485b1e
5a095d43a6cb207c855ca0b8d70d314f6454e5358b1cf4cf2e9dae378e33e3c3
5a5f39391fbf5b06db84b8f9716d53de575ee97a627d2c5f12f79a991a671eb5
5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7
5aad5fbd4238981a9ff5e2772ff1353dfe1a801fb49542fe157418c1438f7782
5d3e035104a91cf73399fee4e2b0c7c5341f2183ede962b29d0d62cae31d4a57
5fb5f7b54d71a8ac603fceec9e2a6560c59dcea9ea178ffb165546cb185f21cc
5fbce8a3467310e80aee477992c4ace2a0492cf074eb7bd808fbc54f1b32841f
6021dc6db79a633312d6f152c30e36ee6f2f42d1c087b7bfc3b7cff887949009
612d588108be3cacc40377b989014ca394cda96a6a1fed922804a2bf58e9c6d5
6169519942b5056579e986436587603b508670d9db194258d453db93c0e10e83
622d4e2da39f5ea961864441f76065bb203bb9053bc3f03c256f42fc5ab1b57b
636d1daf62bd3e2585372b3c622928bd59080b9251b184e32f8483011103eced
66a9e43130da041760046dff8d3a2d021fa45a1d24811a7bf6642ea46bfd9047
6ab9e406e592c81d9d01d0117cf7ba1e796046d7193493baf6f70feee258a56c
6d68efd39e7462337c72fb7e3ceb57eaed7fd0ef9f952d8a5f48f78361c299ef
6eae212fd161b7b43204e54fc106f36b0bd6b373762af8074d7e843b5a4a08eb
6f1c6db27477e74d8c721077c8da5096006d8c5f0d8144b7ddb1ad10c435ac92
6f58202a14e2dcb4c672d6e9f0881ddc2b4e88225a97aadd940400a7377ee02d
706e4d8669d29a9e13cfb13a59b6c1341ec80a08c9c10eaa465756366006f327
72531dc7cd31356b74af7404cd355296fe63fff689ceef1ca2f7bc3081c728ba
76d53e1090957412624c5923a30381ec8d815307bca6c3d88050047ce715da1b
77aef0593cba55488a7ceddae4d3298189468f289a286724fd241e3d7756008f
7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050
799aeb25cc0373fdee0e1b1db7ad6c2f6a0e058dfadaa3379689f583213190bd
7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89
7c77990bc88d4b4834ee62a3ceb8da90c2e24be3d1b44209b6404d1865b99217
7d3c7c58e0a4fbc40dae789bebe500a3d0d837f43df558f52af1052c4936f82c
7d9b7ee9ae860b2f27e08578dacc166269ab838417994fb62c568ff40245b5a3
809ec973a018b6bf8ac18e74bfffc3d25182e6f44df00128d531cf3e07570ee6
80f3cd533d51b52615070047f26baf82f1883577822eb11e2dc51a96c86cfd95
83287a12d21cfaff8bec28bed69c0a77db4bbf689eb609046fc83e84d4eae41d
83c5ebd47131aa8aeef9d7ace04d313c997b67934791fa92c366e78e99242329
8632413702d41d0dfcd1b7037b0aaf256af0a0318462ea217f4647e6f7037055
8821cd10861112ac07254592b0b332abd02cfb6ac32c0ac71378be0fb58c309f
882bf461f27b3300b442ffdef8f95ecae78d562ad63e686182fd06b558d00c66
88a7f2522dd8c93c1f5007fcbcd059cff32a895cdab67e4d0398e94e950fbb65
89851c36a6269b4cde4732f7ae4daa688596d4a822603b6af86d361fc11f4771
8a13903882d971cebc8c1062aaf2158127dfc3f482f1fcb864451fe8cd803b18
8a539ece7f6e7477bc1ddf72d1a3f977fee067352471fadc0cd31705f9fd4739
8bac631dfefdb96cf5526520c21e9ef3f585bba973970a7e62b10c945741105c
8f74e61d48c9e52b3c8d1bcdad624fe6c872bf718db48c52eb3009619bb6a606
916e414630f998f62d89b58f0e2f8262c33fe2d91e274f2a302b9a69b4c91e0c
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
9808e9a37df4741d8a212c739cae654d1e935e3d3f9251c9eef6be7bb24b1eab
9d2e812a4b7d908811b4498cfa2a5b02fc04f974f3fc1fe41187b298a395776b
9e0206d7fbd04e129433b165f9d6eb325fb64d93d0320c39c0c1a2aa0af9ecd7
9e832759eb73e07aa5cb8d9f961625d2c4e5903de4e5ee34cbd413c0338d790d
a222f393763fe4813aae036c1793bcd7422d39db10415f47ef297b274e70b947
a3b6ab755795c30c7cdfa86b65120df5170d6d5b27454a852202e9cec31d2d89
a57dbc8a722b9e87f5cec63cb0b3a3df697edf62499a807deda579a667d63486
a6233fa56c20eaa849e341dbb3f778e8caee83d4fecae8fcafb2f1cb266bba87
a7264081b33c946fb9232348c105505667dabc9c6d1f45a3716e1ed0a779e306
ab21762c3f447aa08cbefd5ea3866165f925bd5058a9ae19e23721462de6fb60
ac854adf2992b4e4e4418bb689417ee2b0ac643f2069e1ada14c4bdf1c71297b
aceb906b19be5a14a045dc9d5c9b04b948ef85f4aff28394e7453bea3c3d9422
aecd7eb2b6e701d96fa190da001f4d25401b8d8c9fba92e3638cda852b27d2c2
af7ec4a5a1c1a3284cccf2fb2cb66721693795d7e37dfe6fbb54439a1e31baaa
afa9c32be463f8f904da58a52ffdd8e60d68273959cae633bd89efbb27fa5b64
b041e7b08a99e947327a5faf96e5ab7aeef39a467c0ef2240710a19857743da3
b0ca3abdfbab847952c45c3a8f2f583be363263f54d8b34ad1604de0278191e2
b1fb822e7c6fe10be230ba2bfcca03b9b8169e9e43aa3b1a5fcefda12e04ec6a
b36b3e9fe37de4ed754769f24ea6b1e57f2fd245a55e0a2e7d815cf7057b922e
b426c235ad88e21d669aaf6226c60c196d041c6e74e507443af32d6541d55f4a
ba51d8f85784fb67039473299849fd954a076e8f809a26cc0ec099fd79f56056
bc1ee17c223d2645e9e2946eeca21fcfc620b5e1addee2524f1bfeb82f900467
bd57bc6badafb2b490f765fd705fa2d53896f040e7b4b538bb70456ec97644cf
bdbf202cd096103d51142548fbc224c54daec112d86dc4fd4a1bd123dddc9927
bfa4aa7cbd4c5dda6856193395db1b900cc1231ff7c73e2b14a6dac2c84fad6e
c0d7eace6de7a123701ad163455f50ea9f6f51c5985a49f4d1f6e797009fbdb1
c235f21017bcc11fcaa31d7dfd9855aaebcbf5f6d7ee9bf9f2e98a910907c391
c4dfcf0a7f1361d7343478a34b55ac4f8e93eeb3946e207910c1d5c6f40399bc
c548ab92911cb0c3db4cbbe04248ddbfd4f50759d33b73ba54f6086cb7716b68
c987e781b10abf844435f183bcd52a253a8615c29fdf534911ef4e4e79cc1f76
ca7154cdda62b535ceaba9ad2a2b2217ff49de94c069a2c4e89733f3f06b3651
cc6a070341f6c03aaac68c47067dd5f5629e6a7eb5b22dbafad7b53830c828b5
cc7403bab52ed166e24ea9324241045af370be482f5b594468f4a6ac6e7e7981
ccf00d1923b0131a10e0c6d26f95e5dee6ebf8621a27e83c5a2f68a2e0093142
ce55bc99e72635134b52b67a2092468d366fce524b0902077b94a7ea39a5bded
cedc9155263d1f634191e71f3c9ce256b315f833e375739ed0e65087996428cc
cf629ea2a78255c90faaef3c4a206b48b608f0d302f8704f45e26005cf9a7aa6
d06528b8fc8644ed639df5ca7863c353785c73629c5f7739d9a6f430882d532f
d0a77e495359613dd0f75850a9b9a541f059b6f215c76acddb418bedb7a2cf6b
d14d732f8caf915919ff661157edc3456a85f408b7a3c5ee1e21357e7df07e1a
d27bc752105c079f8a516e9142406a9fc12cbb409f9bf8681f2ddfe0360b52a6
d455ab882af3a742e6c9680578e6a590681bda99e34847f550f1f41a7d167969
d70cefeb3756aa26506147fe2a965b8f3c438cc1536ca3095c4575735be1686a
d8503c041e7f21942aa95fcd5992a29989cb49116d3cb3bf096455658498417a
da343c70bf28bee6a1a9238dd5147b190b675a523e525e9a52b2bd9aaf48e4e1
daaebd8f5c4ada75f9a08b6bde0a25d3cb9bb4c87e4f78d4a242d3c94a373a0c
db0fe819895d07af230d0f21f183ae4c9ecdec27664f004c6ac8844deaf55adc
db7e0b393e175f19922fefbdcaa2866fca209c521d01cc834ae06cbf8d0f91b7
dc15061d8c788e977befdf83b405f229f96556c3fb1c31e18958a66f20754f0d
dc8276f14c8c80382fe030dfae4fb34e503d5e3557a54e1793fa5c6bc5d6001e
dd870101ad4e95d687a2eb734707b0dd7c20808f76d7be77a71a5d13cf99401c
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
df064da943ce28c544cd3da59dbffc0216fa5c9030f4bbd1a44a5731880424fe
e0243ca2778c12801255144cef22a1b95740c2bf343c0b65286fb36d1c8da029
e19a0e64789068d756a1b250084e54bb0ef77da66685e3dd9eafdc9a71ea1406
e2f925db6119917230e885b016055a6a324d33b10585d5c7f106665ec157754e
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e58980e660fd864229056443fc952d6f9e890eda03c1983ffd807d9c621a2e8f
e81ed9b95f47aba3ebc923849774acef379dfb142c47f4208e733c3283e867c0
e8db51ce4c14ff5417396b03f3a5eca97fd1f2682bbfdb54acf80bafa95852e7
e8e3b7e10ae5885f316f79ea863d10b8f7400484c871da9fbf78fb2caba9a15c
e9ae795603fcb77ad3373c66ad4f06849a0c86fa557c223762e29fd66ed08009
ebe74dcd5581784a9d1d1d3346e7b1423d054c32689efa4ebc1b2c904f85a233
ed2516f391792da401a9be67a828efd5d1853b94571d7b824dbf1dfcfdbb5e90
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f2276a18ac86fbba1d9887c34f938fcc98fed12d9a09b03fb5688988d750bb50
f2f3090410eabc60e4d5ea0683ecf04ed48d018cf4f9e32521d8aa5ea4193fbd
f30769ea0b80a5d900c5f0de30b1aad1ab461195e69223d5ef63c2c5de8b6c1a
f6aa246ff197457e3ea619a18ea12ef8160e787d0f22c3a350e061bb5f3fab4a
f7cea32499cc55e5232ec287c438644afef28297f4248958ee32906dd34ae5f8
fa53fcd8da139d256c0ca83b69cb37473ca627b6052368ed3327c80d9fb61e25
fe65077a468cd59053551033596f3ca0b7380271b89f00a8f58a66ce7162a9cc
ff4bd34aa98a0214833619d3d751838db015722dfbbec15cd14dadc66cd67869

www.europeanpharmaceuticalreview.com Open in urlscan Pro 2606:4700:3108::ac42:2bbe Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Detected technologies

Page Statistics

207 Requests

99 %HTTPS

78 %IPv6

23 Domains

30 Subdomains

27 IPs

4 Countries

4405 kBTransfer

8279 kBSize

28 Cookies

28 Outgoing links

Redirected requests

207 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 1 data transactions

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

www.europeanpharmaceuticalreview.com Open in urlscan Pro
2606:4700:3108::ac42:2bbe Public Scan

Screenshot
Live screenshot

Full Image

207
Requests

99 %
HTTPS

78 %
IPv6

23
Domains

30
Subdomains

27
IPs

4
Countries

4405 kB
Transfer

8279 kB
Size

28
Cookies

207 HTTP transactions
1 data transactions